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CHAPTER I
INTRODUCTION
PARA THYROID HORMONE

History and Origin
Surgeons in the early nineteenth century noted that a
ca.mon after-effect of the removal of the thyroid was the
development of a neuromuscular syndrome ranging trOll mild muscle
spasms to severe tetany.

Approximately 50 years later the

discrete entities which were called the parathyroid glands and
believed to be non-functional, were found closely associated with
the thyroid gland.

In 1880 Sandatr=. (102) first discovered the

external parathyroid glands and in 1891 their existence was
confirmed by Gley (46).

The discovery of the internal parathy•

roid glands was d-.onstrated by Kobn in 1895 (64).

Vaasale and

Generali (115) established the relationship between the parathyroid glands and tetany.

Thyroidectomy performed without

cognizance of the parathyroid glands resulted in tetany
attributed to the raaoval of the thyroid aland.

In 1908

MacCallum and Voeatlin (74) established the relationship between
the nervous manifestations of parathyroidectomy and the level of
serum calcium.

Skeletal chana•• incident to hyperparathyroidism,

although imperfectly understood, were first described by Von
Recklin&bauaen ( 116) •
During 1925 the parathyroid aland attained the status of an
endocrine organ when Hanson (49) and Collip (28) independently
accomplished the isolation of a physiologically active extract

2.
fran the glands.

Thus was ushered in the modern era of

parathyroid hormone research in which the chemistry and mode of
action of parathyroid hormone have been intensely studied.
The site of secretion and storage of parathyroid has been
linked to the chief cells of the parathyroid gland.

Using the

technique of Lmmunofluorescence, Hargis et al. (50) demonstrated
parathyroid hormone overlying the cytoplasm of the chief cells
of bovine, human, and rat parathyroid glands.

This technique

showed no specific staining with oxyphil cells in human tissue,
a cell type previously linked to parathyroid hormone secretion
and storage.
The secretion of the hypercalcemic agent, parathyroid
hormone, is governed directly by the concentration of calcium ion
in blood (22, JO, SO, 86, 104).

This relationship has been

conclusively shown by measuring plasma hormone concentrations
following changes in glandular plaama calcium concentration
effected by perfusion.

care et al. (22.) using radioimmunoloaieal

assay techniques demonstrated that perfusion of goat parathyroid
gland with blood containing 14'- calcium led to an 80% decrease
in parathyroid hormone secretion within one-half hour.

Subse-

quent perfusion with low-calcium blood led to a rapid increase in
hormone secretion to seven times the suppressed value.

Recently,

Ramberg et al. (93) have presented data to indi.cate that parathyroid hormone is continuously secreted at a rate which is
proportional to plasma calcium coneentrat:ion.

3.

l"lost of the current assay procedures employ a. modification

of the Munson technique (81) which utilizes the parathyroid
hormone-induced mobilization of calcium into the blood of rats
as the parameter for assay.

The use of thyroparathyroidecto-

mized animals has greatly improved the index of preeision of
thle assay due to the lack of interference from thyrocalcitonin

secretion which might be expected to supress increases in plasma
calcium following the administration of parathyroid hormone.

The assay is sensitive to 2 USP units of parathyroid extract.
The concentration of parathyroid hormone in plasma can be
measured by a much more sensitive technique developed by Berson
et al. (14).

The assay employs the principle of competitive

inhibition of binding of highly purified parathyroid hormone,
131
labeled with
I, to specific hormone antibodies which are
produced in guinea pig.

Extracts of the serum or tissue to be
131
assayed displaces the antibody bound
t-labeled bovine
parathyroid hormone according to the respective concentration
of parathyroid hormone in the test material.

Such an assay can

detect as little as 10 uug of parathyroid hormone.
Chemistry
Nearly all studies concerning the isolation and characterization of parathyroid hormone have been confined to that
entity extracted from bovine &lands {7, 52, 73, 90, 97).
techniques employ a three stage isolation procedure:

1)

Recent
acetone

. 4.
dahydr.ation aDd chloroform
parathyroid alancla, 2)

extra~1on

these acetone powders with either
8 M urea - 0.2 ! HCl - 0.1

of freshly frozen

defa~tina

of the active priaoiple fraa
9~

H cysteine

phenol or a mixture of
followad by solvent and

salt fractionation, 3) INOeeaaive ael filtrations of the eru4e

TCA precipitate uains various aradea of Sepbadex and finally
carboxyaetb¥1celluloae.
The bomone molaoule obtalnecl by either phenol or tbe urea -

HCl • cysteine method ia bioloaieally &ad chemically the aame

(52).

Potts and Aurbaoh (90) ha,. reported tbe isolation of a

minor c•ponent la the eaC'b.,.ethyloellulose material which i l

biologically, laauaoahaaloally, &ad cbealoally atmilar to the
major caapoaeat but baa a allahtly different amino composition.
These workers have preaeat. . the only detailed reperts coaoend.q
the priaary aaiao aeicl aequeace of parathyroid hontone.
have isolated aDd

They

detenlaecl the sequence of a car:boxytarainal

peptide conaiatt.na of 20 ad..Do ae1c1 naictuea which retains •oat
of the

~aologleal

of the parent

activity and 301 of the biological activity

ho~.

The loss of bioloat.cal activt.ty of pa&"ath)'l!'old honone by
\

tnatllent with H24Ja or perfenal.e ae141 baa been eloa,ly correlated
vith the rate of ox1dat1cnl of aethloalae naiduea to . .tbioalfte

sulfoxide or: me1:b1onlne sulfone (95).

Of the two aethionille

realduea present l.a par:athyroid hormone, only one is belieV«<d to
be necesaar:y for bioloaical

aotl~ty

(90, 107).

. s.
Biological Reaponae aDd Mode of Action
1 t baa been c l•rly shown that parathyroid b.oz:mone has
a direct action on both bone anc:l kidney ( 6, 89) aDd. to soae
extent on the gastrointestinal tract.

Tho major function of the

hos:mone i.a to maintain the caleiua ion activity of the extra•

cellular fluids within physi.olo&ical U.aita.

The total effect

of the hormone on all three major taraet orsans 1a to conserve
body stores of calcium.

Rasausaen (94) pnsentecl one of the first detailed reports
U..nldn& parathyroid homcme and the absorption of calcium from
the gastrointestinal tc-act.

He fO\md tb.&t parathyr:oidectcmy

consistently decreased the abaorptioa of calcium from the
of axperimatal animals.

aut

It was ocmcluded tbat paa:-athyroid

hormone is neoeasary for normal ealeium absorption.

Birge, Peek

and !HidD (16) reported that calcium absorption ia increased ln
huma.n1 with hyperparathyroidism.

However, in order for parathyroid bOJ:mone to act on the
abaorptiOA of calcium from saatrolntestinal tract, vitamin D

must be present in aufflcieftt quantity (32).

The administration

of parathyroid hormone bas no effect in attmulatina the absorp-

ot vitamla D•deficiat ard.mala (SS).
Converaly thyroparathyroidecto.y ot vlc. .ia 0•4efio1«Dt an1mala
cloea not deol'ease the absorption of calcium fr<a the aut aa it
tion of oalctl\D fr• the gut

would in nos:mal anlllala.
actlon and vitamla D are

lt appears that parathyroid homoae
int~tely

aesoelated with respect to
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calcium absorption.
The administration of parathyroid hormone to mammals
produces a rapid increase in urinary excretion of phosphate and
an initial decreased excretion of calcium and magnesium.

Beuter

et al. (lS) showed that a reduced urinary excretion of phosphate
followed parathyroidectomy.

They also deaonstrated that in-

jection of parathyroid extract produced a hyperphosphaturia.
Ito et al. (S9) found a 701 increase in the tubular reabsorption
of phosphate following parathyroidectomy.
There is evidence to iDdicate that changes in glomerular
filtration rate are not respon•ible for hormonally-induced
changes in ion excretion and. that the renal tubule is the site
at Which the hormone acts

(SS, 77). Although the exact site of

parathyroid action upon the renal tubule remains unsettled, most
investigators favor the view tbat its major action is the
inhibition of proximal tubular reabsorption of phosphate (23, 54,

77).

Others bave indicated that the action of parathyroid

hormone may involve active phosphate secretion in the distal
tubules.

The studies of Nicholson (83) and Nicholson and

Shepherd (84) on the nephron of the dog kidney which was selectively damaged by nephrotoxic agents augested hormone stimulation
of phosphate secretion.

In either case the postulated mechanism

of hormone action would be to increase the concentration of
inorganic phosphate within renal tubular cells.

In the proximal

tubule, this would lead to diminished tubular reabsorption by
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increasin& the concentration gradient to be surmounted at the
lumi.nal border {84). and at the distal site where luminal
phosphate concentration is lower it could lead to phosphate
secretion.
Action in Bone
Since the skeletal system contains 98'%. of the body stores
of calcium• parathyroid hormone regulation of plasma calcium

must in some way involve bone.

Parathyroid hormone has two

major direct effects on bone:

to prcmote resorption and to

inhibit collagen synthesis in the formation of bone.

Gaillard

(44) using the technique of bone tissue culture demonstrated

these effects quite clearly.

Incubation of explanted mouse

bone•rudLments with relatively high concentrations of parathyroid extract (Lilly) produced well-defined histological changes
in bona.

Microscopic examination of the bone shaft revealed a

loss of osteoblast•• an increased number of osteoclasts, and
active resorption.

Rat.sz (91) confirmed these observations

using bone rudiments pre-labeled with calcium-45.

The calcium

of the medium in which these rudiments were incubated with

parathyroid hormone. was consistently higher indicating that the
hormone was producing active resorption in tissue culture ..

Hiatolo;1eally 1 this resorption was associated with osteoclastic
proliferation and decreased osteoblastic activity.
Talmage and Elliott (lOS) by applying the technique of
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peritoneal lava!1e, d81lonstrated that parathyroidectomized rata
could mobilize calcium from bcme at the same rate as do normal
rata.

They concluded that the site of action of parathyroid

hormone must be on the deeper trabeculae and not on the moat
recently deposited calcium.

There ia aeneral acceptance that

the regulation of blood calcium ia physiologically a two-fold
proeeaa:

blood • bone ion transfer which is responsible for

minute to minute baaeoataaia and a slower acting parathyroid
hormone component which is responsible for hour to hour
homeostasis.

The blood - bone ion transfer affects only the

labile calci.UIIl which occurs in newly fot:'mlng

and surface

areas

of bone while the parathyroid function affects the stable
calcium located in the well-established mineralized areas of
bone.
It baa been shown that parathyroid extract and the metabolia of citric acid are intimately associated.
principal body reaevoir of citric acid.

Bone is the

Citrate aulysls of

alcohol extract of bone obtained from parathyroid extract-treated
and

no~al

animals, revealed a significant increase in citrate

extractable from the bone of parathyroid extract•treated
(36).

an~ls

Others (77) have noted an increase in racU.oactive citrate

from pyruv.ate-2-14c during the incubation of freshly isolated

bone frasmeots obtained from parathyroid extract-treated
The data was interpreted to mean that parathyroid extract

stimulates the fOJ:m&tion of citrate from its precursors.

an~als.
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However, J:!1 '!'\tro studies by Vaea and Nichols (100, 113)
indicate that the metaboliam of citrate in mouse metaphysis
occurs at about ten times the rate of synthesis.

Since bone

cella have the capacity to metabolize the acid more rapidly than
it can be formed. it would be more likely that t:he parathyroid
extract effect in bone is on metabolism rather than synthesis.
Bone cella can indeed ayntheaize citric acid, but elevated

levels of citrate obtained upon parathyroid extract administration cannot be entirely attributed to increased synthesis; they
are probably due to a blocking of citrate metabolism in same
manner.
There have been ae.,.ral reports on the influence of parathyroid extract on bone metabolism using the techniques of both
short term and lona incubations.

Cohn (2.7) and Conn and

Foracher {26) have studied the production of labeled carbon
dioxide from Krebs cycle and alycolytic intar.mediatea by rabbit
femur alices prepared from parathyroid extract-treated and
control animals.

The production of labeled carbon dioxide from

Krebs cycle inter.aediatea such aa citrate, auccinate, and
fumarate was reduced significantly by femurs of the treated
animals.

However, the release of labeled carbon dioxide from

glucose was increased slsnificantly by bone slices obtained from
parathyroid extract-treated antmals.
Mecca et al. (78) studied the same parameters as did Cohn
but used a system of embryoaic bone in au lt:ura for several daya
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with varying amounts of parathyroid extract.

labeled

ei~rate

The metabolism of

in parathyroid extract-treated cultures was

depressed in comparison \rl.t.h eontrol preparations.

However •

similar studies utilizing radioactive glucose and pyruvate as
substrates showed no effect with respect to the release of
labeled carbon dioxide.

They also prepared nomogenatea from

calvaria cultures and used them to study the release of labeled
carbon dioxide from citrate.

No differences were detected

between control and paratbTroid extract-treated calvaria homosenates until nicotinamide adenine dinucleotide phosphate {NADP)
was added to the bone preparation.

With this addition a decrease

in the release of labeled carbon dioxide from parathyroid
extract•treated calvaria was noted.

The addition of

t~DP

waa

probably required because the preparation of the homogenate no

doubt disrupted the cellular or&anization• and not because of any
altered parathyroid extract•induced effect produced in the
hOi:IOgenate.

There are then two distinct cellular processes in bone
which haw been observed experimentally to be influenced by
parathyroid extract:

bone

~sorption

and bone metabolism.

Resorption is a complex process involving the diaaolution
of both mineral and oraanic matrix.
which is initially removed.

There is no agreement aa to

The r•oval of the or&&l'lic m.atrix

is in all probability an enzymic process, and there are two ways
at least in which parathyroid hormone may control it:

by
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inducing the

ayn~heaia

of new enzymes, or by acti vatins latent

ones already present ill acne inactive form.

There ia some

evidence to support each viewpoiftt.
Evidence in favor of the first alternative are the obser•
vations that the administration of inhibitors of RNA or protein
synthesis (actinomycin D or purOilycin) inhibits the bone calcium
mobiltzin& effeots of parathyroid hormone
and

ia Dt1'9 (44, 91 ). lD

ia :dr.:f2 (69. 96, 106)

y:l~r9 stucliea by R.aisz (92) indicate

the parath)rZ'oid homone•induced nlease of calcium is biphasic:
an early release wbich ia not inhibited

by actinomycin D and a

later progressive release whJ.ah is actlru::nycin D sensitive.
Ra•ussaa ( 96) aubstantiated this obaervatiOD 111 .D,m when he
observed that parathyroid hormone adainistration to actinGmycin
D•treated animals caused an early rise in plasma calcium which

was not sustained aa in control animals.

These data augest

that this hoaaone baa aa tramec.tlate effect upon bone resorption
which does not involve a change in enz,ae
effect which 4oea.

~thesis

and a later

Raiaz (92) also reported an apparent

competition between actina.ycin D and parathyroid

h~one

by

d•onatratlns that i.ru::reaaing the concentration of parathyroid
honone overc•ea the actlnCIIlycin D inhibition.

He has suaaeated

that the two agents coapete for a binding site on DNA.
Vaea (114) baa presented e'Vldence which indicates that bone
resorption may be brought about by the
eDZ)'Illes.

ac~ivation

of latent

He baa shown that bone cella contain •-brane•bound
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cytoplasmic organelles called lysosames, which contain a number
of acid hydrolase& capable of participating in the hydrolysis
of bone matrix.

Activation of the lysosomal-bound enzymes

would require only the rupture of the membrane.

Vaes has

demonstrated that at least sa.e of these enzymes are released by
bone in tissue culture under the influence of parathyroid
hormone.

His premise is that in a suitable acid environment

resulting from the accumulation of organic acids, hydrolysis of
the matrix can readily occur.

He proposes that the action of

parathyroid hormone is similar in this respect to that of
vitamin A which has been shown to promote the release of lysosomal enzymes in cartilage (39).
To understand the mechaniam of parathyroid hormone action
it is necessary to determine the effects of the hormone at the
cellular level, especially in light of evidence linkins parathyroid hormone and RNA synthesis.

This is extremely difficult

to show in bone, mainly because of the low cell density and the
marked heteroseneity of the cell population in this tissue.
Consequently, studies of this type have been approached using
homogeneous cell preparations (19, 111).
Borle and Neuman (19) have shown that HeLa cells srown in
monolayer cultures resorb dead bone chips when incubated with
parathyroid extract.

Morphological changes in cell membrane, a

decreased cellular calcium, and decreased adhesiveness of the
cells to glass were also noted as a result of paratb¥roid
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extract treatment.

Similarly, Tenenhouse, Meier, and

Rasmussen (111} have demonstrated that Ehrlich acites cells
respond to parathyroid hormone.

A two phase system was

utilized in which cella were first incubated with the hormone,
then the supernatant from the first phase was incubated with
45ca-labeled non-viable bone powder.

The release of 45ea was

used as a measure of parathyroid hormone activity.

As little

as 1 ug per ml of parathyroid hormone caused a significant
increase in 4.5ca release. In this particular system, there is
no contact between cella and bone powder.

The stimulation of

calcium release is therefore the result of the action of some
factor released by the cells under the influence of parathyroid
hormone.

This effect is prevented by the addition of actin•

omycin D to the first phase.

This observation suggests that

RNA and protein synthesis are required for the production of
the calcium-releasing factor.
It is possible that bone lysosome, protein synthesis, and
metabolism are

int~ately

function sequence.

connected in the parathyroid hormone

Parathyroid hormone causes the release of

latent and/or synthesis of bone destroying enzymes.

The

accumulation of organic acids attributed to parathyroid hormone
activity will maintain an acidic media at the resorptive site
which in turn ensures the optimal activity of the bone destroying acid hydrolase&.

Besides ensuring optimal enzyme

activity, the accumulation of acid products, particularly
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citrate as sur,?;ested by Neuman and

Nfrull\llll'>

(

82) would lead to

the physical (non-enzymatic) di.ssolut:ton nf bone mineral.

The

citrate ion :ts a potent chelator of calcium ion as well as
being capable of ionizing three moles of hydrogen per mole of
citrate anion.

Blood citrate concentrations are sensitive to

the parathyroid

sta~1s

of the animal.

L'Heureux and Roth (72)

reported increases in both serum calcium and citrate after
injection of parathyroid extract to normal rats.

Parathyroid

function dependent concentrations of bone lactate and one
carbon acids also play a significant role in the resorptive
acidification process.

IS.

THYROCALCITONIN
History and Origin
The events leading to the discovery of a hypocalcemic
principle believed to be involved in blood calcium homeostasis
were set ift motion early in 1961.

Copp (30) observed that

injections of certain preparation• of commercial parathyroid
extract produced an initial hypocalcemic reaponse prior to the
expected hypercalceaia in the teat

an~al.

Perfusion of the

parathyroid-thyroid apparatua in tbe dog with hypercalcemic
blood resulted in an overall decrease in serum calcium (31).
Copp concluded that the parathyroid gland was tbe source of a
hypocalcemic principle which he named "calcitonin•, since
removal of the parathyroid &land before perfusion abolished the
obaerved response.

Kumar et al. (67) originally presented

evidence which confirmed the parathyroid origin of the hypocalcemic agent, but later indicated that the thyroid was the
primary aource of calcitonin (68).
There is now a general consensus with the pr•iae
originally presented by Hirsch (SS) that the thyroid aland is
the prineipa 1 source of a hypocale•ie honone named thyrocalcitonin (TCT) as opposed to the postulated parathyroid
hypocalcemic factor, calcitonin (13, 20, 4S, 47, 112).
Thyrocalcitonin baa been isolated in quantities sufficient for
assay from the thyroid glanda of several species (47) includin&
the rat, dog, goat 1 ox, monkey and human ( 1 ,3, S3, S6}.

16.
Hagis ( 48) by means of immunof luoresence technique,
detected thyrocalcitonin in the eytoplasm of all epithelial
cella of porcine thyroid glands.

SiMilar teehniquea applied to

porcine parathyroid glands did not detect the presence of
thyrocalcitonin.

Pearse et al. (87) hAve postulated that the

thyroid C cella manufacture and store thyrocalcitonin in a form
that is available for rapid release.
Recent developments indicate the possibility of the
existence of two different hypocalcemic factors in the calcium
homeostatic system calcitonin frcm tl\e parathyroid gland (4, 21)
and thyrocalcitonin from the thyroid aland.
Aaaay
The~:e

ia no atandarcS uait of

rather such unite are

arbit~:arily

doae•reaponae relationahip of the
under coaaideratioa (56 1 68, 103).

tb.y~:oealcitoain

acti vl.ty, but

defined in accordance with a
paJ:tieula~:

aaaay procedure

Moat procedure• aeaaure the

fall in serum calcium aa the parameteJ: for aaaay.

The Medical

Reaearch Council of &ritain in an effort to eatabliah a uniform
unit of activity baa prepared for diatribution viala coatainins
a thyrocalcitonin preparation of a defined potency of one M.R.C.
unit (56).

Tbe moat salient characteristic obaer.ed in

thyroealcitonin assay ia the rapid onset of a deer•••• in serum
calcium of the teat aotmala.

ln fusion of 50 mug/min into the

tail vein of a 100 &r• albino rat will produce a 1% decrease
in serum calcium within 60 minutes ( 68).
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CheaiatJ:Y
Tb¥rocalcitonin ia prepared from acid extracts of thyroid
glanda, u.ually porcine thyroid alanda (47, 53, 8S).

The

acid

extract ia subjected to aolveat and aalt fractionation and ael
filtration to produce a hiahly purified product.

Porcine

thyrocalcitonin obtained by four different approaches uain& the
above procedure (S3) ia a ainale obain polypeptide of a
molecular wei&ht ranae 5,200 t 800.

An appreciable amount of

bioloaical activity of porcine thyrocalcitonin ia lost upon
treatJaent of the homone with hydroaen peroxide, and n • brcaaowcclnamlde ( 108).
Biological Reaponae and Mode of Action
Infusion of thyrocalcitonin in rata will produce hypophoaphat81Dia cODccaitant 'with b.ypoealc•ia aa well aa a paaaive
hypoealciuria and a abort

t

em hyperphoaphaturla ( 88, 98).

Thyrocalcitonin markedly inhibits bone reaorption both in vi$£0
and

in l1!2 (43, 45, S1, 60, 63, 75, 76). Riatoloalcal

ex•lnatlon of bone culture• incubated with parathyroid hormone
and thyroealcitcmin, c.t•onatl'ated that thyrocalcitonin can
arrest pal'athyroid hormone induced bone reaorption ( 43, 4S).
Injection of thyrocalcitonin into aataala wboae bones are prelabeled with 4Sca produces a decreaae in the turnover rate of
45
ea ia both the labile and atable fl'actiona of bone calcium
(S7, 60, 63).

How.ver, the inhibition ia more pronounced in the
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stable fraction of bone (57).

Using the technique of lavage

removal of calcb.lm from bone, Klein et al. (62) observed that
thyrocalcitonin produced a marked supreasion in the removal of
calcium.

These observations tmplicate bone and possibly the

kidney as target organa of

t~rocalcitanin.

Another potential

tar&et organ of calcium homeostasis, the aastro-intestinal
tract, has been show to be unnecessary for thyrocalcitonin
action (2).

Studies em the influence of thyrocalcitonin on the

lumen to plasma ion flux of leola ted pat aepents d-.onatrated
a statistically insiantfieant decrease in flux (66).

Recycling

a fluid of known calcium concentration through the gut loops of
anesthetized doas injected with thyrocalcitonin produced a rapid
fall in aerwa caleb• but no chana• in aut calciUII concatration (65).

The questicm whether the kidney is a taraet oraan

at all remains controversial.

Reports can be culled from the

literature which cover an entire spectrua of results with
respect to phosphate excretion and thyrocalcitonin.

Some

workers ( 79, 99, 100) reported experlaents which detected a
definite relationahlp
phaturia.

be~en

thyrocalcitonin aDd b¥Perphoa-

Othera ( 98) have d•onatrated a short term byper-

phoaphaturia, while Pechet et al. (88) report that thyrocalci•
tonln lnjectl.on produces decreased exeretlon of both calcba
and phosphate in rate.
Sl.nce parathyroid hormone and tbyrocalcttontn have directly
opposite responses with respect to bone resorption, one ai&ht
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expect that thyrocalcitonin inhibits the secretion of or in
some way inacti.vataa parathyroid hormone.

This does not seem

to be the case since thyrocalcitonin is effective in parathyroidectomized antmals (2, 55) and there is no evidence for the
thyrocalcitonin inactivation of parathyroid hormone (2).

The

primary site of hypocalcemic actioa of the boraone appears to
be at some ataae in the resorptive process of bone (62).
Thyrocalcitonin and parathyroid

h~an•

probably do not caapete

at the aa.e site in the resorptive process (SS), but rather if
one eoa.aiders bone resorption a stepwise procesa, thyrocalcitonin
exerts ita effect at a step oeeurrina earlier in the resorptive

proeeaa to that aite which is aenaltiw to the hypercalcemic
hoxmoae, parathyroid horaorae.

20.
BONE METABOLISM

1! VITRO

Although bone contains several heterogeneous and quite
distinct cell types it is believed that the metabolic pathways

in these cella are basically the same.

The overall pattern of

glucose metabolism in freehly isolated bone differs very
slightly fraa tbat pattern of slueoae metabolism which would

be found in any typical cell (26).

There is a difference in

the prtmary metabolic end prOduct of bone cell metaboliam and
that of ordinary tissue cella.

The faet that S0-60% of the

metabolized alucoae is converted into lactic acid is believed
to be a refleetion of the low oxyaen tension in bone cells

caused by the isolation and aluaaiah circulation in the
riaversian Systems.

Freshly isolated bema ill a simple buffer

exhibits an anaerobic pattern of slucoaa metabolism (17 • 26)
eve in the presence of

oxyaea.

The anaerobic nat:uJ:a of boaa metabolism perhaps leases

the importance of Krebs cycle activity, but it doea not entirely
obliterate ita importance.

The classic acid resorption theory

of bone relies on the ability of citrate as a potent chelator
of calcium ion.

Citric acid wae believed to play an

~portant

role in parathyroid hormone resulation of bone resorption (82).
Moat of the lactic acid fol!"llled in bcme will eventually be
metabolized via the Krebs-citric acid cycle.

The met&boU.em of bone is not exclueively liaited to organic
acids.

Skeletal tissue contains coasiderable lipid of diverse
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types (37, 71).

It baa been shown lipids can bind both calcium

and phosphate (9. 40, 61).
bone is not known.

However, the exact role of lipid in

A lipid material has bean demonstrated at

the sites of active calcification (58).

This same unknown

lipid material disappears from rachitic bone only to reappear
when calcification is stimulated by vl.tamin D.

The lipid

material was not as demonstrable in older more calcified
skeletal tissue.
CI.'Uess and Clark. (33) noted that the lipid composition of
bone vas altered by toxic doses of vitamin 0 or vitamin A.
Administration of vit•irl A decreased the total fatty acid
conttmt of cortl.eal bone while vitamin D wa1 observed to increase
trialyceridea, esterified cholesterol and phospholipids in bone.
Protein and •lao acid metaboli• 1.a bone are important in
the fomation of the orsarli.c eollagea aatrix.

Collaaen syn-

thesis in isolatecl bone aepen.ts will COiltiaue for at least
eisht hours

is Xitro (34, 41).

Collagen ia formed in cella and

is released as a relatively stable component of the organic
matrix.

Bone matrix synthesis is OXY'&tm dependant, since

collasen synthesia is stimulated by glueoae and inhibited by
anaerobiosis.
There have been two aeneral approaches in the atudy of bone
metabolism 1g

~s;o;

namely, the use of freshly isoLated bone

segments and the use of bone tissue cultures.

Each of theee

technique• have inherent advantaaea and diaavantagea.
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Freshly isolated bone fragments are usually employed in
short term experiments.

The short term aspect allows a precise

control of incubation medium and allows one to study tissue
performing a wide variety of functions; glycolysis, amino acid
transport, fat synthesis and the formation of collagen.

The

less durable cells of the isolated fragments die soon after
isolation.

The overall viable state appears to be 6 - 12 hours

in which the initial metabolism of surviving bone approximates

--

the true in vivo state of metabolism.
The prolonged term incubation of bone cell cultures
involves complex factors.

The consistency of the media

necessary to support such an incubation is quite difficult to
control owing to the presence of inumerable constituents.

Most

synthetic tissue culture media require the addition of serum.
This necessitates obtainin0 a uniform supply of serum from a
single source in order to prepare consistent incubation media
over a period of time.
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Statement of the Problem
There ia considerable evidence which indicates that parathyroid hormone (PTH) and thyrocalcltonill (TCT) have a direct
action on bone, the principal taraet oraan of these two
calciua reaulatins hononea.

Ntaeroua reports have appeared

coaeemins the relationabi.p betveera parathyroid extract (PTE)
and the metaboli.. of alucoae and oraanic acids in bone.
However, purified parathyroid homODe does not influence
metaboliaa

AD Xilto ( S2)

a a indicated in the Ehrlich asci tea

carcin-.a cell aaaay.
of

14

Thia assay aeaaurea the flux in production
fro. alueoae-6-1 4 c or p,yruvate-3- 14c in tuaor cella

~

incubated with peptidea of variable aetabolic activity.

PTE

and non-calcium aobilizina fractions obtained durin& the
purificatiOD of PTI will stimulate the production of 14 co frOil
2
the aforalentioaed aubatn.tea but purified PTH baa no effect.
There have been no reports to date cODoer:aina the relationship
be~en

tbe thyroealeitonia aDd the oxidation of substrates.

lt is currently tHllieved that the metaboliam of oraanic
acicla in bone .ay not eonatitute a direct role in the aechanlea
of acticm of calcium hCIIIleoataaia aa previously proposed (82),
but rather the releaae aad ayntbesia of heme deatroyiq eDZJ'IIleS
(114) may be the primary inU:iator:a of the hyperealc-ic
reaponae.
The postulate of N8Uflan and Neuman ( 82) indicated that PTH
produced ita hyperealcaaic action by inoreaaln& localized
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acidity in bone via PTH-induced alteration in the rate of
accumulation of acid products of bone metabolism which would
dissolve bone mineral.

PTH could increase acidity at the

resorptiva site by either increasins the metaboli.a of alucose
to orsanic acids and COz or by blockina the oxidation of organic
acids so as to cause their aecuraulaticm.

However, recent

evideDce indicates that bone resorption is not quite as a imp le
as the procaas outlined by Neuman and Neuman.

Many cmzymes

have been ahown to be involved in resorption (114).

PTH action

bas b-n shown to be dependent on m•IUfA synthesis ( 91 ) indicating
that the synthesis of protein, probably enzysaea, is involved in
the raecb.aai• of action of PTH.
Since the hJpercalc..io principle• parathyroid hor.mone,
does not affect oxidation of substrate .111 yJ.tn, it would be of
interest to discover the aaent wbich does produce the fluctua•
tions in metaboli.. of alueoae and oraanie acids commonly
associated with the injection of PTE aad PTH, and the relative
iaportaraee of thue fUftcticma with reference to the aechanisa
of action of the hypercalcemic response.

Also, thyrocalcitonin

bas a direct effect on bone (2) and is a PTH antaaonist (63) on
many levels of PTH action.

Information concemin& the unexplored

relationship between TCT and bone metabolism might be helpful in
establishing the relativa iaportance of alterations in the
oxidation of alucoae and oraanic acids in the overall mechanism
of calcium homeostasis.
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The approach co the problem will be a modification of
the one . .ployect by DeLoaa and L 1 Heureux ( 35).

The bone

preparation• will be uaad to relate the hormonally-induced
metabolic pbanaaena (thyrocalcitonin and parathyroid extract
induced alteration• in the evolution of C02 fro. aubatratea)
with the hormonally-induced pbyaloloaical and hiatoloaical
phenaaena (parathyroid extract and thyrocalcitonin altered levels
of serum calcium).
Two of the anataaieally diatlnct realons of femur will
serve aa tlaaue apeoiaena; the cllapbyaia Uld epiphyeia.

Theae

two realona were choaan beoauae of aarked difference• in
phyaieal atructure and eell cllatrli!NtiOD.
theae difference• say be reflected in the

It I.e poaaible that
a~ion

of PTE and

TCT oa theae tlaauea.
A lao

the lnf luenoe of c:a lciua ion oa the oxidation of

substrate will be studied la.an effort to establish a direct
relation betweea substrate oxidation rate and calcium ion
ccmc81ltratlon ill yJ.tro and J,a .D.:m•

CHAPTER 11
MATERIALS AND ,._iETHODS

G19eral

gxper~ental

Prgsedyrt

Male Holtzman albino rata wei&hing approximately 140 - 170
grams were tbyroparathyroidectcmized in order to remove the
influence of endogenous parathyroid hormone and thyrocalcitonin
The animals were prepared in the followirag manners in

activity.

order to study the desired experlaental parameter.

1.

Parathyroid extract treatment and bone metabolism.

The animals received two injections; experimental animals

received 75

u.s.P.

unite of Injection Parathyroid (Lilly) and

control animals reoeiwd a comparable volume of vehicle at 24
and 48 hours after suqery.

The vehicle injected was that used

in the commercial preparation of the extraet and was coaposed of

1.67. alycerol,

2.

0.2~

pheaol and

o.~

sodium chloride.

Calciwa ion com.....ntration and bone metabolism.

ln order to study !J1 vivo calcium ion c:oncentration and bone
metabolia. the
and

n<m~al

aa~ala

wwre maintaiued on calcium deficient diet

diet for a period of cme week.

The

J.a Xi5E9

effect

of ca lcl\.a icm on bon.e mecaboli• was studied by incubating bone
tissue in media Wbich contained v.arioue concencrationa of
caleium.
3.

PTE, PTE-TCT tS'e&t:ment and bone metabou.••

The animals were prepared as in procedure 1.

However, twelve

hour• after the last injec:ticm of PTE a group of PTE treated
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an~als recei~

subsequent injections of TCT over a two hour

period.
In all the experiaents, the bone tissue was prepared auch
in the same marmer.

A weiped porticm of bone frapents or an

aliquot of bone hc:aosen.ate was placed into a 25 ml incubation
flask which coatalned a suitable ineubatlon m*.U. UIIl.

Fraputs

and bomoaenates were prepared from both the diaphysis and
epiphysis of f..ura obtailled fr• all teat an111lala.

B.adioactive-

ly•labeled aubatrate waa added to each f laak and the f laak was
sealed with a

~bber aep~

in which io inserted a plastic

centerwell contalnina a 101 solution of KOH.

The incubation was

carried out in a shaker water bath at a t•perature of 37° C for
a period of three hours.
After three hours the nabla tlaaue was killed by the
addition of 2 ml of 101 trichloroacetic acid to each flask.

The

10% solution of KOH whieb waa coatained in the cuterwell was
transferred to a culture tube.

The labeled carbon dioxide

absorbed in the KOH solution was precipitated as bariua carbonate
and the radioactivity waa detem.ined.

SIJWM QALCIUM DETQH1RAJ:1Ql1
A method of deteminina ionizable calcium in serum, which
is essentially unaffected by oraanic materials present, bas been
reported by Ashby and Roberta ( S).

Thla method ia baaed upon

the fact that at pH's above 12, calcein (an iainoacetate
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derivative of fluorescein) fluoresces under lcma•wave ultra•
violet li&ht only in the presence of free ealclua.

In an

analysis, a siven a.ount of ethyleaediaainetetraaeetic acid
(EDTA) 11hich is in excess of that required to eompla all of the

caleiua present is added to the ••ple.

A amall 8t'llOUDt of

cyanide is added to CGIIlpla any cropper or ira which is present.
The solution is back•titratect vlth standard calcl.\8 soluticm
wtth the calci\118 replacia& the

~Mpeei\S

camplex which might have fonlad.

l.n aay mapeaium.-EDTA

WheD all of the EDTA has

beocae COIDplexed with ealci\D, additicmal ealeiua will c•bine
wtth ealoein eaueina fluoree..acet al\d the end poiat will bave
been reached.

Titratioaa must alao be performed on calcium-free

••plea ia order to deter:alDe the total calcl'Uil biadina capacity
of the EDTA aliquots.

The aena calci\D level is determined

from the difference betwaen the total oalelua binding capacity

of the EDTA and the amount of calcium required to titrate the
serum aaple.
lour hundred microliters of blood sample were obtained from
each rat by tail bleedina.
refrigerator for a abort

The ••plea were placed in the

t~e

before the clot vas separated by

a five minute centrifugation in a leokaan/Spineo microfuge.
Thi~y

microliter aliquots of serum were added to microtitrator

cups.

To eaeb cup vas added 0.150 ml of 0.001 t{ EDTA, Ofte drop

(about 60 ul) of dilute calceia indicator, 1 drop (about 30 ul)

of 1'1. sodb• cyanide solutl.OI\ 1 and 1 drop (about 60 ul) of 1.0

29.

! sodium

~droxide.

Titration was performed with a micro-

titrator containing a 20.0

mg~

standard calcium solution.

A

lona-wave ultraviolet laap (Mineralisht• Model SL 3660) was
placed about tvo inches above the titration cup.

The standard

calcium solution was added with continuous stirring until the
green fluorescence which was
intensity.

obae~

no longer increased in

The calciUI'I concentration of the sample is directly

proportional to tbe difference in microliters of standard
calcium required to titrate the sample and a water blank.

10.0

ma~

A

standard caleiu. solution was run with each group of

samples and the calcl\D concentrations were calculated as
follows:
m&" ca leiu. • 1 0 ms~ x ais;olitU'I ftr
microliters or
Where:

iftM:f
•& standard

microliters unknown • microliters of titrant required to
titrate blank minus microliters of
titrant required to titrate unknown
sample
microliters 10
standard

ma~

• microliters of titrant required to
titrante blank minus microliters of
titrant required to titrate 10 m&1.
standard

figure I indicates the linear relationship between the
microliters of titrant used aDd the concentration of calcium in
solution.

This is the standard calcium titration curve used to
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TABLE I

STANDARD TITRATION CURVE DA.TA FOR CALCIUM DETERMINATION

Aetual

Number of

Microliters

~lliY!I

i&.:JlRlll
6

30.7 +
- 0.2

Oml"

!' II.UUt

Microliters
'II.~EI•~ • 0 mill

6

6

20.6 t

o. 3

10.2

8

6

17.3 t 0.4

13.4

10

6

13.9 - 0.3

16.8

12

6

19.9

14

6

16

6

10.8 +- o.s
+
7.5 - 0.2
+
4.9 - 0.3

+

23.3

25.9
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calculate serum calcium concentration for the antmala uaed in
the esperinumta.

The data for this standard curve appears in

Table I.
SilutiO!liS
calceip eolutiS!!•gonc•tratt4.

0.2S

a

of powdered indictor was

dissolved in 4.0 m.l of 1.0.! NaOH.

When solution was

c:Oilplete this was diluted to 100 ml with doubly distilled
water.
Calot\n indt.sasor solyt&s.

o.s

ml of the concentrated calcein

solution vas diluted to 2S ml with doubly distilled water.
C!li\UI 1tapdtrd eolutiop.

0.2497 1 of ov.n•dried calcium

carbonate vas dissolved in 30 ml of 2
SOO ml with doubly distilled water.

!!

HCl and diluted to

World.na solutions were

prepared frOID this stook solution.
!thyl!Btdlfll!ttttE!ICetls 11\d ttfD41£d•

0.375 & of EDTA

dissolved in COz·free water to a total volUSBe of 1000 ml.

fLgqD SAMPLII9:
Blood aaaples were obtained fr• the tail of the rat.

The

rat was placed ia a reatrainlna caae aDd the tail severed
approximately three quarters of an inch fro. the tip.

Bleedin&

was aided by "allk.ina" the tail in a proxillal to distal
direction.

Blood was collected in plastic m.lerotubes, and these

were allowecl to stand at rooa t•perature for thirty minutes to
oae hour to allow for clot formation and retraction.
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Centrifugation was performed in a Beekman Spineo/Microfuse for
two minutes.

Supernatant serum was separated fro. centrifuaate

and stored under refrigeration ln a aicrotube until analyzed.

IHDOfABAIHXI91DMOO:
Thyroparathyroldectcay at birth. results in a severe
retardation of arowth. and skeletal developaent.
are leas severe if the operations are

perfo~ed

The chana••
at later aaes

and usually require a period of weeks to beccae aanifeat.

The auraical tecblllque •ployed ln the tb.yroparath)'roid·
•ct01117' of male albino rata i1 one o-.cmly •ployed in ftWIIaroua

laboratories.

Animals 120 - 140 grass ln velaht are anesthe-

tized vith a dose of aqueous n•butal solution in the proportion
of 33

•a

n•butal/Ka of body wal&ht.

The rat la secured to an

operating board and the head la kept extended by means of a
rubber band which la looped over the upper iaeisora.

A 'ftfttral

midlin.e ak11l incision. is made aten.41n& sli&htly beyond the
upper and lower boarders of the submaxillary aland.

The

salivary alanda are aently teased aaide aa any unneeeaaar,y
trauma will cause severe blee41na and the underlylna musculature
opened at the aidllne by blunt dissection.
~ediately

the lllUBCUlature

aurroundlna tba traachaa ia teased apart at the

midline and retracted • th.ua expos ina the two lobes and the
isthmus of the thyroparathyroid apparatus.

The alands are then

carefully teased frcm the treachea. preferably intact (two lobes
connected by the isthmus} to ensure camplateneaa of removal.
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Af~er ~he

removal of the &lands, a w.dge of sterile cotton

is placed over the WOUrtd until the bleedina is assuaged.
co~ton

The

ia r•oved and the wound ia eloaed by the use of Michel

wound clips.
The anl.mala require fr• three to six hours to recover
fr• the anestheat.a.

Those &ftimals Which developed difficulties

in breathing or severe losa in weipt within two daya were not
uaacl in the axperl.menta.

Durin& the operation, clean but not

neeeaaarily aseptio teebnique vaa •ployed.

The rat does not

readily become infected in the reaion of the neck.

Overall,

male albino rata within a weiaht ruse of 120 • 140 arama seem
to respond better to surgery than beavler animals.

In animala

weisht.na lesa than 100 ara.a, the tbyro1d•paratbyroid apparatus
is often difficult to find.

IHI

PRJfAMilQJ!

2l

fMGMil!TS AND HgtOGIA"fADS QStt

MI

FR!YR

Male Holtzmaa rata were etwmed by a sharp blow to the head
and decapitated.

A eemieircular 1nelalon was aade around the

lea just below the pel'Vle.

The akin wae pulled toward the foot

exposlna the lllUsaulature of the thiah area.

The tendon

COil•

nectina the epiphyala and a portlcm of the musculature was
severed.

The aevered tendon vaa araaped with forcepa and pulled

toward the pelvis.

This procedure tears away moat of the

ventral musculature of the thi&h and expo••• the f•ur.
r•ainiq musculature was scraped away with a acalpel.

The

The
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femur was severed from the tibia and worked free fran the

soeket in the pelvis.

The extirpated femur was placed in ice-cold incubation
media.

The bone was ele&Ded of all adherent muscle, periosteum,

and cartilage.

The distal epiphysis is separated from the

diaphysis.

prox~al

The

epiphysis is also separated from the

diaphysis, but it is discarded.

The distal epipb7sis and

diaphysis were split lonaitudiaally and the marrow r•oved by
serapin& with the point of a scalpel and washina with isotonic
saline.

For the preparation of bone frasments, the aeetions of
epiphysis and diaphysis were blotted dry and weighed on a
Roller-Smith balance.

Approximately lSO - 200 ms of the split

bone sections were fra.-entized

OD

slaaa or lucite plate using

a stainless steel scalpel and placed in a twenty•five ml
iucubation flask containina 4.0 ml of incubation media.

For the preparation of h•osenates 1 sections of epiphysis
and diaphysis were placed in a bone disiatearinder (Kontes)
with 10. 0 - 30.0 al of incubation media depend in& em the amount
of bone to be h•oa..ized.

H•osenlzaticm was performed for

five ad.DUtes or uratil no further contact between the disintesrinder and bone could be felt.
HaaogeD&tes bave a milky appearance and settle out
rapidly.

While

pipet~ing,

a masnetic stirrer.

the hellloaenate ia kept agitated with

Whenever possible tiesue was maintained at
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a temperature of 0

0

C during preparation.

An estimation of the amount of material in any particular
volume of homogenate was obtained by pipetting a 1.0 ml aliquot
of homogenate on a preweighed planchet.
on the planchet using a heat lamp.

The aliquot was dried

The planchet was weighed

and the dry weight of the material in the aliquot determined by
the weight difference of the planchet.

This was necessary so
that the data could be expressed according to 14
evolved

caz

from substrate metabolized by an esttmated amount (dry weight)
of bone present in the homogenate.
PREPARATION OF lNCUBATIQl! MEDIUM

The medium used in these experiments was prepared by
mixing 232 ml. 0.154 H NaCl, 8 ml. 0.154

~

KCl, 6 ml. 0.110 H

CaC1 , and 2 ml 0.154 H Mgso4 , and adding 25 ml of phosphate
2
buffer prepared by bringing 75 ml. of 0.2 ! NaOH to a pH of

7.4 with 2
water.

H H3P04

and diluting to 100 ml. with doubly distilled

All solutions were prepared with doubly distilled

water.
LABELED CARJON DIOXIDE COLLEQTION AND MJA.SUREMENT

Radioactive carbon dioxide produced by the oxidation of
the radioactively labeled substrate in the bone tissue preparation was absorbed in 0.2 ml of a 10% solution of potassium
hydroxide contained in the centerwell of the incubation flask.
The centerwell of the flask also contained a small fold of
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Whata\an 11 filter paper.

The purpose of the paper was to

increase the surface area of contact of the potassium hydroxide
solutioa and to help control mov.aent of the liquid durin& the
incubation in. the abakar bath.
After the incubation period, the filter paper in the
centerwell waa tran.aferred to a teat tube.

Five al of

COl free

distilled water waa added to each tube, aad the contents of the
tubes were transferred quantitatively to another set of culture
tubes which each coatained S al of
solution.

lot.

bariua chloride

The tubes were allowed to stand at room t•perature

until the white, floeky, precipitate settled.
The tube conten.ta were transferred into a Tracerlab

precipitation Apparatus, Model E•ll whlch was fitted with a disk
of Whatman #SO filter paper.

Suction. waa applied an.d the

radioactive barium earboll&te was plated on the disk of filter
paper.

The plated preoipitate was washed aueceaaively with

water an.d dried with acetone.

The plated aa.plea were allowed

to dry for two hours before weiahiD& and eounting.
The coun.tina waa acccmpliahed with a thin end•Vin.dow type
aaaaably consisting of a Tracerlab Tracermatic SC-83 Scaler,
Tracerlab SC-100 Multi•Matic Sample Changer, and a Tracerlab

sc-66 Printing Timer.

Corrections for self-absorption

(2S)

were determined by eatabliahina a aa14co3 aelf•abaorption
curve (Figure 2).

The t:abulated data for the determination

curve appears in Table 11.
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TABLE 11
Ba 14co3 SELF-ABSORPTION CORRECTION VALUES
Correction

o. 0-0.5
0.5-1.0
1. 0-1 • .5
1.5-2.0
2.0-2.5
2.5-3.0
3.0-3.5
3.5-4.0
4.0-4.5
4.5-5.0

s.o-5.s

5.5-6.0
6.0-6.5
6.5-7.0
7.0-7.5
7.5-8.0
8.0-8.5
8.5-9.0
9.0-9.5
9.5-10.0
10.0-10.5
10.5-11.0
11.0-11.5
11.5-12.0
12.0-12.5
12.5-13.0
13.0-13.5
13.5-14.0

1.00
0.95
0.93
0.91
0.89
0.88
0.36
0.82
0.80
0.78
0.76
0.74
0.73
0.71
0.70
0.68
0.67
0.66
0.65
0.64
0.62
0.61
0.60
0.58
0.57
0.56
0.55
0.53

Correction
14.0-14.5
14.5-1.5.0
15.0-15.5
15.5-16.0
16.0-16.5
16.5-17.0
17.0-17.5
17.5-18.0
18.0-18.5
18.5-19.0
19.0-19.5
19.5-20.0
20.0-20.5
20.5-21.0
21.0-21.5
21.5-22.0
22.0-22.5
22.5-23.0
23.0-23.5
23.5-24.0
24.0-24.5
24.5-25.0
30.0
35.0
40.0
45.0

so.o

0.52
0.51
0.50
0.49
0.48
0.47
0.46
0.45

0.44

0.43
0.43
0.42
0.42
0.41
0.41
0.40
0.39
0.39
0.38
0.38
0.37
0.37
0.32
0.29
0.26
0.23
0.21
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FIGURE 2
SELF-ABSORPTION CORRECTION CURVE FOR Ja1 4co3

CHAPTER III
EXPERIMENTAL RESULTS
The experimets utiliZed the detection of

14

c~ evolution

fram the radioactively labeled substrate as a aeasure of the

!a

yitro oxidation of aubstrate by bone tissue preparations.

The substrates ueed in the exper~enta included citrate-I,s-14c,
sueet..nate-2 •,_14c, 2-oxoslutarat..s- 14c. and pyruvate·2· 14c.
The oxidation of these substrates was atuctiecl using frapenta
aDd MADP fortified hamogenates prepared from the diaphysis and
epiphysis of f.aurs exclaecl from the various teat animals.
The data an presented for each flask used in the

incubation aerlea.

The parathyroid atatua of the experimental

and control animals was assessed on the basis of their
respective aerua calcium levala.

The blood aamplea were

obtained immediately prior to sacrifice and analyzed later for
calcita concentration.

The elapsed tinle between sacrifice of

the anlaals and the beainnlna of the experbumt ruaed from
2 • 3 hours • durba wbich time the tissue was prepared for

incubation.

Tbt lncub!ti9D o( ram•!• 2f [ENE Pl•Rh'ttt.•
apd IRJ.RhYtil PDRH:fd frc;g fiE-IEftted M4 CptJ'ol Agi.malt
lm>tr!Un$ 1'

!ita CJ.tr•tt:l.-s14Q.
Slx thyroparathyroldectaaized rata were used ln the
experiment.

Three of the six were injected subcutaneously with

parathyroid extract and three with vehicle.

Tbe rata which
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received 150 u.s.P. over. a period of

two

days showed an averase

increase in serum calcium of 2.9 mg%.
In the experimezat, 1.0 mt.crocurie of radi.oaetive sub-

strate, 150 .. 200 ma of bone frapents aDd 4.0 ml of t.ncu.batiOJ'l
media were present in eaeh t lask.
out for two hours at 37°

The incubation was carried

c.

The results of the experiment appear in Table 111.

The

diaphysis of the femur showed a depreasion in the oxidation of
substrate by the bone preparation obtained fram the PTE-treated

animals.

The epiphysis of the f..ur exhibited an increase in

the oxidation of the radioactive substrate by the bone
preparations obtained from the PTE-treated animals.
E2SJ?eriJe&t 2;

tht lgcy,b,asion tf ,F;apaJ!.t• Stf Fsur Diaphrsis

and Epiphysis fr:c:p fiE·Tnatn •14 Coptrol A;imala with
susslnett·2.l-1 4 c,
Biabt thyroparathyroideetomized animals were used in
Experiment 2.

Four of the rats reoei ved subcutaneous injections

of 150

u.s.P. units

days.

The control antmala received a comparable injection of

vehicle.

of parathyroid extract over a period of two

The PTE-treated

an~als

had an average increase in

serum calcium of 2.7 ·~·

Two mierocurt.es of auccinate-2.3-1 4 c, 200 ma of bone
fragments and 4. 0 ml of incubation media were present in each

of the incubation flasks.

The incubation was run for three and

one-half hours at 37° C in a constant te:aperature shaker water
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TABLE 11!

LABELED CARBON DIOXIDE PRODUCED FROM THE
CITRATE•l,S-

14

c

BY FAAGMENTS

or

OXI~TlON

OF

FEMUR DIAPHYSIS AND EPIPHYSIS

DlAPJIYS:tS

Experimental

Aetivity

's:•lu

S!!bllE•!I

Qsmsti:tig

Citrat:e-1,.5- 14c
Cl.trate-1,s-1 4c

PTE-Treatment

22

PTI•Treataeat

31

14

C

Ccmtrol

S2

14C

Control

49

Citrate-1,.5Citrate•l,S.

bene l

EPIWJ§lS

Experillleatal
Condition

~!ab&UiE•!i!

Activity
~smlm&

Citrate-1,.5-

14

C

PTE•Treattnent

19

Citrate-l.s-

14

c

PTE-Treatment

23

Citr.ate-1,5- 14C

Control

13

Citrate-l,s- 14c

Control

10

bone}
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bath.
The diapb¥sis of the femur showed a depression in the
oxidation of substrate

by

the bone preparation obtained from the

PTE-treated animals when CGalpared to that of ccmtrol anltaals.
The epiphysis of the faaur produced an increase in the oxidation
of the radioactive substrate by the bone preparation obta1Ded
fr• tbe PTE-treated animals (Table lV).

!xptJ1RW 3:

TM INN12!tlop

ap4 Ea1pbra1t PrtRff!d (tl!
with

of

fiiPMtf gf l'lfiNt D1aphxs1s

ETI-Treattf

apct C!ft;rol An11fl•

PJrul!tt:2-1 4 g.
SS.x thyro,aratbyroidecta.i&ed rats were uaed in the

experlaeat.
with 150

Three of the aalaals were injected subcutaneously

u.s.P.

units of paJ:athyrOid atn.et and three were

injected subcutaneously with

~icle

over a period of two days,

The rata which were injeatecl with parathyroid extract showed an

averaae increase in serua caleiua of 2,8

•a~.

Two mic:roc:uries of ractioactive substrate, 100 •1 of bODe
frapenta, and 4,0 ml of media wen present ira each incubation
flask.

The incubation was performed for three hours at 37°

c.

It can be seen from the data preaented in Table V that
the diaphysis of the femur showed an inereaae in the evolution
of 14co2 by the bone preparation obtained from the PTE-treated
antmals,
of

14

The epiphysis also showed an increase in the evolution

c~ from the radioactive substrate by the bone preparatioa

obtained from the PTE-treated antaals.
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TABLE IV
LABELED CARBON DIOXIDE PRODUCED PROM THE OXIDATION OF
SUCCINATI•2,3-14c BY FRAGMENTS OF FEMUR DIAPHYSIS AND EPIPHYSIS
RlAPHJSlS

Sub! tEAS!

Exper:laeatal
QoMitiop

Suecinate-2,3-14c

l'TI•Tr:eatment

29

Suecinate•2,3-14c
Succ1nate-2,3-14c

PTE-Treatment

30

PTE•Treat:aent

31

Suocinate•2,3-1 4 c
Succinate-2,3- 14c

Control

48

Control

44

Sucolnate-2,3-14c

Control

38

Activity

<£111/m' bont)

EPIPHXSIS
IQ1$EIII

Experimental
COftdL$1:19

Activity

<cnalraa ,., >

Succ:laate-2,3-1 4c
Suc:einate-2,3- 14c

PTE•Treatatent

88

PTE·Tr:eatiMftt

71

Suec:inate-2,3- 14c

PTE·Treatment

72

Suoe1nate-2 1 3·14c
Suoelnate-2,3-1 4c

C011trol

53

Control

Suooinate-2,3-14c

Control

''ss
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TABLE V

~~~~!~!~~,~~ ~~O~~~~~~ug~B~~D~~~~i~!~~NE;iPHYSlS
DIAPHYSIS
Exf.ierimental

Subatr•$1

Condit ism

Pyruvate-2- 14c

PTE-Treatment

Pys'UV&te-2- 14c
Pyru.vate-2-1 4 c

Activity

'epmlms bone)
382

370

PTE-Treatment

367

Pyruvate-2- 14c
Pyruvate-2- 14c

Control

264

Control

222

Pyruvate-2-14c

Control

203

Sybstrate

ggmtitiop

Pyruvate-2-14c

PTE-Treatment

780

Pyruvate-2-14c
Pyruvate-2- 14c

PTE-Treatment

800

PTE-Treatment

920

Pyruvate-2-1 4c
Pyruvate-2- 14c

Control

.564

Control

574

Pyruvate-2-1 4c

Ccmtrol

610

Experimental

Activity

(cme/•s bone)
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Boae cella are diat:ribut:ec.t unevenly t:hroupo.t: the bone
tiaaue.

Oaeification centers and arowina areas of bone will

have a deaser cell populatioft tban older, completely mineral·
ize4 areas of bone.

In the preparation of bone frapente the

poaeibility exists of inadvertently "loadina" an incu.bation
flask with tissue containin& a preponderance of living cells
and

another with tiaaue containina mainly non-viable material.

Also, the radioisotope must penetrate the intricate canals in
the fragmentized Haversian system of the f.-ur in order to come
into contact

with

the viable cell.

This means that production

of 14COa from labeled substrate vill at least partially reflect
the ability of the labeled aubstrate to penetrate into the cell.
Thus a method vaa devised to obtain a more physically

uniform bone preparatiOD with the use of a bone diaintesrinder
( Kontes)..

The homoaenate prepared throuah the uae of the

disintearinder was rather coarse and bad to be kept agitated or
the

mil~

auapenaion would rapidly settle out.

To measure the

homoaeneity in the various homoseaatea prepared, one ml aliquot&
were pipetted into preweiabed planchet• alld dried.
aliquot• had a vei&ht variation of
of a 1 ml aliquot.

!

0.20 m& in lS

The dried

ma,

the wei&ht
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gxperlmgta 4 aDd 5:
D\aphyeis and

Iemur

The Ingubation ot !Jomosenates of

En!Rbf•l• Prepared

from PTE-Treatt,d and

Contro~

~nimals wi~h.gitr~te-1&~-~4c,
Four thyroparathyroideetamized rate were used in eaeh
experiment.

Two rats were injected aubeutaneously vi th

parathyroid extract and the control antmals were injected with
vehicle.

The animals which reeeived 162

u.s.P.

units of para•

thyroid extract over a period of two days showed an average

inerease tn serum calcium of 2.1 tDg% in Experiment 4 and 2.4 mg,.
in Expertment S.

In !xperi.ment 4, 0.5 mieroc:urie nf radioactive substrate
e.nd 4 .. 0 ml of homogenate were present in each flask.

ineubati«m was run for thr4'tf! hours at 37°

The

c ..

Femur diaphysis and epiphyais showed no differences in the
oxidation of .ubstrate by bone preparations obtained from the
PTE-treated rats when camparfl!d to that of control preparaticma ..

(Table VI).
In Experiment S, one microcurie of cltrate-1,5- 14c and 4.0
ml of bone homogenate were present in each ineubation flask.
The lneubat:1.on was performed for three hours at 37° C in a

eortstant temperature shaker water bath.

Femur diaphysis and epiphya1a showed no differences in the
oxidation of aubstrate by bone preparation obtained from the
PTE•treated animals when compared to that of control preparations
(Table VII).
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TABLE VI
LABELED

CARBO~

DIOXIDE PRODUCED FRQvi THE OXlDATHiN Or"

CITRATE·l,S-1 C BY HOHOGERATES OF FEMUR DIAPHYSIS AND EPIPHYSIS

PlhfHX§I§
Suhftrate

Experiaeatal

Activity

ConditiOJj

( qpa/m& bon•)

Citrate-l,s-14c

?TJ:!:-Treatment:

45

Citr.ata-1,5-14c

PTE-Traatment:

43

Citrate-1,5- 14c
Cl.t:rata-l,s-14c

Control

41

Control

PiPlP}JXSl§

Experimental

Activity

'•waa J2onel

SJJJ!IS£•tl

sta~&!&!l

Cltrate-1,.5- 14c

PTE-Traatlaeat

64

C1trate-l,s- 14c

PTE-Treatment

67

Control

65

Control

63

14
C
14
Citrate-l,S- C

Citrate-l,S·

49 ..

TABLE VII
LABELED CARifl DIOXIDE P&OOUCED FROM THE OXIDATION OF
CITRATE•l 1 S• C BY HOMOGIIATES OF FEMUR DIAPHYSIS AND EPIPHYSIS
DJAPHJSIS

Subttrttt
Citnte-t,s-1 4c
Citr:ate-t,s- 14c
Citrate-t,s-1 4c
C1trate-t,s- 14c

Experimental

Cta41S\•
PTE·Tnatmeat

Activity
(qa£raa bsms)

26

22
COiltrol

22

COI'ltrol

24

EPlPHJSJS
lxperi.aeatal

Aoti'rity

S\IJa•tntt

ga•a:s\a

Ct.trate-l,s-14c
Citrate-t,s- 14c

PTE•TrMtment

36

PTE•Treatlltmt

34

C1trate-t,s- 14c
Citrata-t.s- 14c

Coatrol

34

Control

33

hnalu

boa l

so.
Eperiatpt 6:

Tbt lgsubation of Homoaenatt• of Feu£ DiaRhYaip

!Q!I lpipbr!\1 PrtHnf fng PTE•Tre&ted &M Ct!t£01 Agimtll
14
with Sgscinate-2,3-

c,

Four tbyroparathyroideetomi&ed rata vere uaed in the
experiaent.

Two of the rata were 1ajected aubc:utaneoualy with

parathyroid extract and two were iajected with vehicle over a
period of two days.

The animals which each noelwd 162

u.s.P.

units of parathyroid extract d . .onl'trate4 an averaae increase
in aerua calcium of 2.9

a&%.

One half microcurie of radioactive substrate and 4.0 ml of
hoaogenate were present in aac:h flask.
for three houre at 37°

c.

No differeacea ia the evolutioa of
either the

diap~aia

The incubatioa was run

14

co2

vere noted iD

or the epiphysis prepared either from

PTE•treated and coatrol ant-ala (Table Vlli).

lxaerlaat l M4 8; Tat IDGHiiH !( fJOIIUM!tts of FEN£
Pi•Pb't•il aa• bipbytif lDMEft , , . PII yd COgt£01 AglMll
!i~b frrvl!!t=2-14g,
Four thT£0Paratbyroideetoaized rata were used in each
experiment.

Tvo of the animals were injected subcutaneously

vitb parathyroid extract and two were injected with vehicle over
a period of two days.

The rats which received 162

u.s.P.

units

of parathyroid extract showed an averaae increase in serum
calcium of 1.8

•s" in Experllaent 7 aDd 2.S ma" in Experlment 8.
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TABLE VIII

~~~i~T~~!~t£~O~iD~~~~~~~S~~F~RO~~~~~sO:No
DIAPHISlS

Experiaumtal

Activity
'gpmby. b9ftl}

Sybstratt

Qoad~tston

Sueeinate-2,3-14c
Suecinate-2,3- 14c

PTE-Treatment

19

PTE-Treatment

18

Succinate-2 1 3-14c
Succinate-2 3•1 4 c

PTE-Treataent

18

PTE-Treatment

17

Succ1nate-2 1 3- 14c

Control

19

Suceinate•2 1 3-14c
Succinate-2,3- 14c

Control

lS

Control

17

Succinate-2,3-1 4 c

Control

19

1

EPlPif(SlS

E.:xperimenta 1
CoadlJ:lM

EPIPHYSIS

Activity

Sueeinate•2 1 3- 14c
Suee1nate-2,3- 14c

PTE•Tre&tllltmt

<male• bsm•>
ss

PTE•Treatment

60

Suec1nate-2,3- 14c

PTI•Treatllent

57

Succ1nate-2,l-14c

PTE-Treatment

ss

C

Control

ss

Succinate-2 1 3-1 4 c
Succ1nate-2,3- 14c

Control

53

Control

56

Control

S7

Sul»etrttt

Suceinate-2,3-

Suce1nate-2 1 3-

14

14

c

52.
One-half microcurie of radioactive substrate and 4.0 ml
of homogenate were present in each flask in Experiment 7.

One

microcurie and the same amount of homogenate were present in
each flask in Experiment 8.

The incubations were carried out

at 37° C f~r three hours.
The diaphysis of the femur showed an increase in the
oxidation of pyruvate-2-14c by bone homog~na~e prepared from the
PTE-treated animals.

The epiphysis of the femur also showed an

increase in the oxidation of substrate by bone prepared from the
PTE-treated preparations.

This pattern was observed in both

Expertments 7 and 8 (Table IX and X).
It is apparent from the results (Experiments 4 - 6) that the
homogenization procedure has a profound effect on the ability of
the bone tissue preparation to detect hormonal treatment on a
metabolic level, as indicated in the absence of alterations in
the oxidation of organic acid. The preparations were viable in
that 14co2 was produced from eitrate-t,s-14c and suecinate-2,314c, but no differences could be detected between the PTE•
treated and control preparations of diaphysis and epiphysis.
This finding is similar to that reported by Mecca et al. (78)
in which case homogenized calvaria were viable but showed no
differences in the oxidation of organic acids when incubated
with PTE as the tissue did when intact calvaria were incubated
with PTE.
However, comparable homogenate preparations incubated with

TABLE IX
LAffL!D CARBON DIOXIDE PRODUCED FRQ1 THE OXIDATION OJ! PYRUVATE·
2· C BY HQ100ENATES Of' FEMUR DIAPHYSIS AND EPIPHYSIS
DJ.!P!.iX§l§

Experimenta 1

Aetivity

iYJ!IIE•Sil

~Ol'ldii&ID

'CJ!Ilal

Pyruvate-2-14c
Pyruvate-2- 14c

PTE-Treatment

780

P'l'E•Treat~aeat

810

Pyruvate-2-14c
Pyr:uvate-2-1 4 c

PTE-Treatment

960

PTE-Treatment

840

Pyruvate-2-1 4 c
Pyruvate-a- 14c

Control

570

Coatrol

580

PyJ:uvate-2- 14c

Control

580

Pyruvate-2- 14c

Control

sso

iP&flii§l§

Experimental

Activity
'IJBial JIOD!l

§yb!l£!11

~21Wi~i2D

Pyruvate-2-14c

PTE-Treatment

1,380

Pyruvate-2- 14c

PTE•Treataent

1,400

Pyruvate-2- 14c

PTE•T&"eatmat

1,590

Pyruvate-2- 14c

PTE-Treatment

1,390

Control

1,320

C<mtrol

1,200

Control

1,200

Control

1,300

14
C
Pyruvate-2- 14c

Pyruvate-2-

Pyruvata-2- 14c
Pyruvate-2- 14c

J!2!!! ~
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TABI~E

X

LABELED CARBON DIOXIDE PRODUCED FaOM THE OXIDATION OF PYRUVATE•
2-14c BY HOMOGENATES OF BONE DIAPHYSIS AND EPIPHYSIS
DlAPH't'S!S

Substrate

Experimental
Conditt on

Activity
~ SPmLmg bon!)

Pyruvate-2-14c

PTE-Treatment

1,220

Pyruvate-2-14c
Pyruvate-2-1 4c

1,100

1,160

.Pyruvate-2-14c

Control

840

PyJ:Uvate-2 ... 14c

Control

700

Pyruvate·2-14c

Control

740

gPIPHXSIS
§yf!!t{&tt
Pyruvat:e-2- 14c
Pyxuvate-2- 14c
Pyxuvate-2- 14c
Pyruvate-2- 14c
Pyruvate-2-1 4c
Pyru.vatt·2- 14c

Expertmental
~!U~~lsm

Activity

LsuaLea bD!l

PTE•Ts:eatment

3,250

PTE-Treatment

2,800

PTE-Treatment

2,900

Control

2,200

Control

2,300

Control

2,300

ss.
pyruvate·2- 14c were aenaitiv. to preparation difference• in
hoz:monal treat:meDt (PTE va. c:ontr:ola, Experiment• 7 and 8).
et al. found that the addition of the cofactor NADP to

Mecca

calvaria haaoaenatea would lnereaae viability of the hoaosenate
aftd reatore the eenaitivity to PTE-treatment, in the oxidation
of oitrate-l.s-14c. No other labeled aubatratea except
c1trate•l,S-1 4c were uaed in tbia procedure.
ln the next aerlea of experiaenta, hcaoaeraatea were prepared
in the uaua l . .aner 1 except that a meaaured aount of NADP waa
added to eaeb h•oaenate.

Thia proeedure waa decided upon to

determine if the addition of thie cofactor to femur homoaenate
would reatore viability and/or aenaitlvlty of the bone preparation to PTE•tre&taent.

EutmtH 9! 1bt IgCN\WliOD

of !f.DP t:utt.fitsl Hsaosgate• of

fWIE DltRhYI\1 u« IRiPbTtil fEtD!rtcl fl!!! fli•IQ!t!d Msl
x?DtJ'!l AnJ•ll !!J.tb C1mtt::l,S-

14

$i 1

Pour thyroparathyroideetcaized rata were uaed ill the
experiattDt.

Two of the ant.mala were injected aubcutaneoualy

with parathyroid extract and tvo were injected with vehicle.
The rata vb.1ch received 100

u.s.P.

unita of injection parathyroid

d . .onatrated an a.,.raae lncreaae in aeZ\111 calclu. of 3. 0 •a%
over the CODtro 1 anilla 11.
One-half alerocurie of radloaeti,. aubatrate 1 4. 0 ml of
homoaenate and 16.0 mieramolea of NADP were preaent in each
f.laak.

The ineubation waa carried out for three hours at 37°

c.
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The diaphysis of the femur demonstrated an increase in the

oxidation of radioactive substrate by bone homogenate obtained
from PTE-treated animals.

The epiphysis of the famu: also

showed an increase in the oxidation of substrate by bone
hamoaenate obtained from the PTE-treated anlBals (Table XI).

Ege@ent \OJ

Ib! Jpc;ubatlOJ)

q( NADP fs!J;ti(l!d Homogenate&

of lfiY£ Diaphy1ia agd lpiphts1a PttP!Eta f£08 PTE•Irf!ted apd
Qoptrol Ani.Ja!l! with Suqs1aftt=2,3- 14g,
Four thyroparathyroideotomized rata were uaed in the
experiment.
100

u.s.P.

Two of the Z'&ta were injected subcutaneously with
units of parathyroid extract; two received a compar-

able volume of vehicle.

The animals which received the

parathyroid injection showed an averaae increase in serum
calcium of 2.6

mg~.

One•half microcurie of radioactive substrate, 4.0 ml of

1omosenate, and 16.0 mlcraaolea of NADP were preset in each

1

flask.

The incubation wa oanied out for three hours at 37°

c.

The diaphysis of the femur ahowwd an increase in the
oxidation of the substrate by the bone preparation obtained
frc:a the PTE-treated animals.

The epiphysis of the f•ur

damonetratad an inereaee in the oxidation of the substrate by
bone preparations obtained from PTE-treated antaala (Table XII).
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TABLE Xl
LABELED CARBON DIOXIDE PRODUCED FltQf Tmt OXIMTlON OF

CITRATI•1,5-14c BY HOHOGIMAT!S OF FEMUR DlAPHYSIS AMD EPIPHYSIS
FORTIFIED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE

DJAPijYSI§

Experimental

Activity

SuliiiEIII

~,,,.

's•l.ma HI! l

C1trate-1,5-1 4c

PTI•Tn&ta8Dt

126

C1trate-t,s-14c

PTI•Treataaen.t

123

C1trate-1,S·.l 4c
Ct.trate-1,5- 14c

C01ttnl

.53

Contrel

59

lflPHXSJS
Expert.a•tal

Activlty

'•WBl•& taal

Sy\t!CFftt

C. Ddla,i2D

Citrata-t,s-1 4c
Citrate-t,s- 14c

PTE-Treatment

385

PT!·Tnatment

365

Citrate-1,.5- 14C
Citrate-l,s- 14c

Control

290

Control

280

0

TABLE XII

LABEfE

CARBON DIOXIDE PRODUCED FR<»> THE OXIDATION OF SUCCINATE·
2,3- C BY HOMOGENATES OP FEMUR DtAPHYSIS AND EPIPHYSIS
FORTIFIED WITH MICOTIIAMIDE ADEIIftl DIKUCLIOTIDI PHOSPHATE

QIAfliXIll
Eapert.a•tal

Activity
(.;a/m~ b9!J!l

§ybttE•l.t

Condit!sm

Suce1nate-2,3-14c

PTE-Treatment

1,280

Suceinate-2,3·14c

PTE-Treatment

1,120

Suecinate-2,3- 14c
Succlnate-2,3- 14c

Cntrol

870

Coatrol

910

J;PlPlfiSJS

Experimental

§»bttDtl

Coa4itlon

Aetivt.ty

'mal•&

bgu}

Succinate-2 1 l·l4c

2,540

Succiaate-2,3·14c

2,4.50

Suacinate-2,3-14c
Suae1nate-2,3- 14c

Control

1,830

Control

2,140
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IXH£t.uns II;

Tbt

&P&ba~icm

of MDP Fortified Homoaetea

of

I:M\11' Qifphyfil 11!4 lpiRhxtl.l P£tR!ted (r99 PTE•Tqab4 and

Qon;rol AaiMl• ¥ltb Pu.uDSe-2- 14c.
Four thyroparathyroidec:tamizect rata were uaed in the
experiMent,

Two of the rata

reeei~

dosea of parathyroid

extract, and two were injected vt.th vehicle.

The rata which

received 100 U.s. P. uni ta of parathyroid extract d•onatrated
an averaae increase 1ft aes:um calcium of 2.5 asS over the level

of the ontrol animals.
One-half mleroourie of radioactive aubatrata, 4. 0 •1 of
homoaenate and 16.0 aieramolea of NADP were preaent in each
flaak.

The incubation waa carried out at 37° C for three houra.

The diapbyaia of tba feaur ahowad aa inoreaae in the
oxidation of subatrate

~

tbe bone homoaenate obtained fram the

PTE-treated anilaala when c•pared to tbat of the control
antaala.

The epipbyaia of the femur d..onatrated an increase ln

the oxidation of the radioactive aubatrate by bone hamogenate
obtained from the PTE-treated
Exper~enta

an~la

(Table XIII).

9 • 11 indicate that the addition of NADP ia

effective ln reatorlna viability to the bone preparation•.

Femur prepared •• NADP fortified bomoaenatea oxidizea citratet,s-14c, suecinate-2,3-1 4c and pyruvate-2- 14c at a greater rate
than control preparations ln both diapbyaia and epipbyaia.

In

the caae of the epipbTaia tia.ue, this ia the aaae pattern of
oxidation which waa obaerved uain& bone frapenta (Experiments
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TABLE Xlll
LAf!LED CARBON DIOXIDE PRODUCED FROM THE OXIDATION OF PYRUVATE2· 4c BY BONE HOMOGENAT!S OF FEMUR DIAPHYSIS AND EPIPHYSIS
FORTIFIED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE

Experimerttal

Activity

(.£m/ms bontl

Substrste

C2Pdi ~i...C!ft_

Pyruvate-2-14c
Pyruvate-2-1 4 c

PTE-Treatment

276

PTE-Treatment

261

Control

202

Ccmtrol

215

§:fiPHYSJS
!xperimenta 1
S&ond!~J:on

§HJ!It&•t!

Pyruvate-2..

14

Aeti'Vity

!sml•s

C

PTE-Treatment

650

Pyruvate-2- 14c

PTE-Treatment

678

14
C
Pyru'V'ate-2- 14C

Control

383

Control

373

Pyruw.te-2•

Jl2n1l
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1 - 3).

However, the pattern of oxidation in the hamoaenatea

of the diaphysis is different from the pattern observed using
homogenate& of the epiphysis.

The rationale for this difference

will be discussed in detail in Chapter IV.
It now appears that bone prepared aa NADP fortified
hamogenatea from PTE-treated antmala will metabolize Kreba cycle
and alyeolytlc intermediates at a greater rate than do control
preparation.

Concomitant with increased metabolic rates, PTE-

treated animals have increased levels of serum calcium.

lt has

yet to be established whether the increased rate of metabolism
due to injection of PTE ia instrumental in atilllulatina increased
levels of serum calcium or whether elevated levels of serum
calcium caused by the injection of PTE are instrumental in
increaain& rate of metabolism.
In explorlna the latter poatulate 1 the following aeries of
experiments were desipe<l to study the !a ntro and in .!!.:!.!!
effect of calcium ion concentration with no hormonal treatment
on bone metabolism.
bJ>er1Jatnt 12:

Tbt Incubata.on of NADP Fortlfa.ld HC!!oaenatea of

Vfrla,te Calglum 109 QonsenSretlon Prtpar!d frga

ft~ur

D\apbysla

and lpiphyala of Noraal Aa&mala !ith PJIYVate·2- 14c,
Slx normal animals were selected for the experiment.

The

f•urs from these anlmala were prepared in the usual fashion
except that the femur diaphysis and epiphysis from the three
pairs of animals were homoaenlzed in incubation media containing

62.
6 m&% 1 10 mgJ. and 14 mg% ealeium respeetively.
One-half microcurie of radioactive substrate, 4. 0 ml of
homogenate and 16.0 micromolet of NADP vere present in each

flask.

The ineubatlon vas can:iec:l out at 37

The mapltude of evolutlOD of

14

0

C for three hours.

c~ appeared to parallel

the mapitucle of calcium. ion pretent in the medium of both
haaosenatea of diaphysis and epiphysis (Table XIV).

Aa the

calcium of the medium was lnereased from 6 ma,. to 14 mg1., the
14
total aaount of evolved
co2 vas increased.
hptrimenS Jl; fbt lDeub,aS12!l tf MDP Futifi§ B9!Pot;enatea

fE!R!rtd

frgp FI!Y£

DitRbZill !ad Ep\phfait of

Ag~lt

Mt1Q•

tatgtd op NO!!fl pnd Ca&c~·dtficlent Diet• with Py;uJ!tt=2- 14c,
Of the four th)'roparathyroideetomlztd ard.mala selected for
the experl.aent, two were aaintal.Dect em a ealclum•deficleat teat
diet (Nutritional Biochemical Corp.) artd two were aud.ntalned on

a normal diet for a. period of one week.

Serum calcium concen-

trations for the calcium-deficient and normal diet anilaals

averased

s.s

m.s~

• 10.6

ma% respectively.

One•half alcroeurie of radioactive substrate, 4. 0 mls. of
hCIIaogenate and 16.0 micrOJDoles of IADP were present in each
flatk.

The incubation was carried out at 37°

c

for three hours.

lone epiphysis and diaph)"ats prepared from uimala maintained on a calct.um-deficlent diet produced leas

14

c~

frcm the

substrate than did thoae bone preparations obtained from
animals maintained on a normal diet (Table XV).

TABLE XIV
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LABELED CARBON DIOXIDE PRODUCED FROM THE OXI~TION OF
PYRUVATE·2-14c BY HOMOGENATES OF FEMUR DtAPHYSIS AND EPIPHYSIS

FORTIFIED \HTH NICOTINAMIDE AlJENl.~H~ DlNUCLEOTlDE PHOSPH'1-TE AND
CONTAINING A VARYING AMOUNT OF ~LClUM ION.

Pyruvate-2-1 4 c
Pyruvate-2- 14c

6 ma7. Calcium

Activity
'~i!!lm& 22!1!l
72

6 sqf. Calcium

80

Pyruvate·2-1 4 c

6 me'- Calcba

99

Pyruvate·2- 14c
Pyruvate-2- 14c

1o aa7. ca lcb•

136

10 •a% Calet.Ulll

118

Pyruvate-2- 14c

10 qt. Calct.um

139

C
Pyruvate·2- 14c

14 ma7. Caleba

17.5

14

•&'-

Calcium

168

Pyruvate-2- 14c

14

ma~

Cal.ct.ua

172

Experimental

DIAPHYSiS

gousU.stsm

§ubs~[a~e

Pyruvate-2-

14

e~:=;~

Experimental
~IJ!d1S19J!

Activity

'sal• l!aosl

Pyruvate-2- 14c

6 ma" Calct.um

207

Pyruvate·2- 14c
Pyruvate-2- 14c

6 ma1. Caleb•

206

6

ma.,

Calcba

218

Pyruvate-2- 14c
Pyruvate-2- 14C

10 ma% Ca lciUID

283

10 mat. Calct.um

29.5

Pyruvate-2- 14c

10 mg'J. Ca. lebam

310

Pyruvate-2- 14c

14

•a' Calcium

3.54

14 ma1. Calet•

360

14 qf. ea lcb•

347

Pyruvate·2-14c
Pyruvate-2-1 4c
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TABLE XV

LABELED CARBON DIOXIDE PRODUCED FRCI'l THE OXIM.TION OF
PYRUVATE•2~14c BY HOHOGENATES OF FIMUR DtAPHYSIS AND EPIPHYSIS
!'ORTlFIED WITH NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPW.TE AND
PREPARED FROM ANIMALS ON CALCIUM•DEPlCIEMT AND NORMAL DIETS

DlAPHY§I§
Experbumtal

Serum Calcium

Activity

''*"'

§ubatas•

!itMiSioa

Pyruvate-2- 14c
Pyruvate-2- 14c

Calcium Deficient

8.8

Calcium Deficient

8.3

98

Pyruvate-2- 14c

Calcium Deficient

8.4

66

Pyruvate-2- 14c

Nor:mal

10.6

120

Noxmal

10.3

117

Nor:mal

10.9

132

Pyruvate-2- 14c
14
Pyruvate-2- c

{ma1,}

bO!)f l

94

CfiP§XSIS
Sub&S£&t!

ExperiraMta l

SU'UlB

~lsla

calcium

'mdl

Activity

'sualu !!Btl

Pyruvate-2- 14c

Calcium Deficient

8.8

227

Pyru.vate·2- 14c

Calcium Deficient

8.3

224

Pyruvate-2-14c

Calcium Deficient

8.4

221

Pyruvate·2- 14c
Pyruvata-2- 14c

NOJ::aal

10.6

391

Nonaal

10.3

381

Pyruvate·2- 14c

Nonal

10.9

340

6S.
Experiments 12 and 13 indicate

J.a

'!it£! aftd

1!1 l'1:D

calcium

ion conc.atratione prior to aacrifiee can influence bone
metaboli•

11!

Y\Sro•

The oxidation pattern presented in the

data of Experlmellt 12 res. .bles the oxiclative pattem presented
by the injeeti.on of PTE in that both the injection of PTE and

hip oOBoentrattons of

i!l

ntrt c:alolUDl lOll ( 14 ma~) att.mulate

bone oxidation of substrate,

Conversely. bOile preparation

lru:ubated in low ccmoentratioa of calcium (6 ma1.) or prepared

from animals maintained on a calcium-deficient diet and bavin&
low sei'UDl calcium values peaseeeed the least oxidative activity
in teras of

14

c~

evolutiOD,

To detenlae whether or not the observed oxidative pattern
is eoneieteat in bona prepared frea aalmale made hypooalc. .t.c
by injection of TCT • the following aeetioa of experiments was

deeip.S.

Jxperlmt!!t 14:

Dt IRIUbttlop

ot

Fraall\!1 li'.IP!Ffd

tr•

tb!

pt.tplw•t.• amt Mph'''' 9f tqt·Tnet!d !!!d £ontaJ.
An'lflt !itb Citrttt•1.~14c,

twur

Four animals were

thyroparat~idectoaized

and maintained

oa a aomal diet ad libitum for two days after surgery.

Then

two of the four aniaala received intraperitoneal injections of

15

ma

of thyrocalcitonin Tel powder dlaaolved in 0.01

aeld ln two doaea of

o.s al

1

over a period of two hours.

acetic
The

control antm&la reaei. . . coaparable injections of 0.01 1 acetic

aeld.

The • ..,_ calcium levels of the TCT•treated and c:o.ntrol

66.
artl.mals averaged 9.8 me;% artd 10.0 ma% respectively.
A weighed quantity (approximately 100 m&) of fl'agment:s of

femur diaphysis and epiphysis was placed in eaeh flask and to it
4.0 ml of ineubaticm aedia and one mlcroeurie of radioaet!ve

substrata was added.

The incubation vas carried out at 37° C

for 3 hours in a ecmstant teperature shaker water bath.
The labeled carbon dioxide produced frem the substrate by

bone preparation• frcm the TCT-treated and control animals was
not different (Table XVI).
Exptrimens• lS

amz

16;

ftgmosenates of Ff!Ur

tht Incubation of NADP

PitRbx•&• tnd

Fottifi~

IR\phttil from TCI•Treated ag4

GO!ltrol An.yala W\t!l CS.trate=1 • .5·1 4 g,
P'our thyroparathyrol.dectOIDiZed animals were used in these
experiments.

Seveaty•t:wo hours after aurgery two of the four

anl.mala were injeeeed wit:b 15
diaaolvad in 0.01

1

of t:hyroealcitonia TCA powder

acetic acid in two dosea of 0 • .5 al each

over a two hour period.
volume of 0. 01

aa

The oontr:ol received a ccaparable

li acetio acid.

Serta calclua values of the TCT•

tl'eated and control animals averaged 8.9 m&!J. and 9.3 ma'J. in
Exper1Daent 1 S and 8. 6 m&'l and 9. 0 mg'%. in Experiment 16.
The f.un were excised, elunecl and hGmogenized.

A

4. 0

ml aliquot of h011ogenate together with one-half microcurie of

substrate and 16.0 micraaolea of NADP were present in each flask.

The ineubation was run at 37° C for three hours in a constant
tasnperature water bath.
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TABLE XVl
LABELED

CARB~~

CITRATE•l,S•

DlOXID! PRODUCED Fl\<M THE OXIDATION CF

C BY FRAGMENTS OF FEMUR DIAPHYSIS AND EPIPHYSIS

FRQ1 TilYROCA.LClTOtUN-TRFATED AND CONTROL AIUMALS.

PMOOSI§
bbtsu;t
Citrate-t,s.1 4c
Cltrate-t,s-1 4c
Cltrate-l,s- 14c
C1trate•l,5-1 4c

Experimental
~op4lt19J1 •

Serum Calcium

<•JJ%l

Activity
(cpm/pt~a

Tct-Treatment

9.4

41

TCT•Trea~ent

9.2

38

Control

10.3

44

Control

9.7

36

bon•l

IPJPif'SlS

Expertaental

Seruta calcium

Aetivlty

'•dl

'crab!&

TCT·Treatment

9.4

140

Citrate•1,5- 14C

TCT-Treatment

9.2

135

Cit:rate-1,5· 14C
Citrate-l,S· 14C

Control

10.3

150

Control

9.7

131

~Y~I~BI:I

g2DdlSi!m

Citrate-t,s-14c

b9J!! l
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The results given in Tables XVII and XVIII indicate that
TCT•treatment does not affect the evolution of 14c0a from
labeled substrate by either diapQyais or epiphysis.
The results of ExPeriments 14 • 16 indicate that the dose

level of TCT administered to the teat atdaals prod.ueea a very
slight decrease in s_,_ oalalua ( approxlutely leas than 0. S
ms~)

and bas no pronOUDced effect on the oxidation of substrate

by bcme.

This indicates that TCT itself does not affect

oxidation of substrates in bone tissue.
Hypercala. .ic animals are more sensitive to a &iven dose
level of TCT than are aomoeale. .ic antaals.

With this in mind,

the last aeries of experiaents were dest.ped to produee a

greater fall in serum caleium per close level of TCT which was
used pre'ri.oualy.

The oxidation of aut»strate by borae was com•

pared in PTE-treated, PTE·TCT-treatecl aacl control aniaala.

The

dose of TCT wbieh was aclal.nistered to PT&-treatect ani.Jilals
produeed approximately a 2
~attran.se

17. 11 !!!4 12:

tJMO&WJtt tf font

ma~

decrease in serum aaleiua.

thl IpguHJloa

PrfBnst fr- Jht

at

@Di! ron\f&Jtd

PI.&Rhysil

M4 IR1Jb.YIJ.I

!( W•Trl;ltt4 1 fTI•Tct•TrttJtd trut Csmtro& Agyalt Bth
14
21tratt:laS- g,
Six thyroparathyroldeet•ized animals were used la the

experlllent.

Twenty four hour:a after auraery, four of the aix

aniaala received 100

u.s.P.

over a period of

days in two doses of SO UBits each.

two

units each of Injection Parathyroid
The
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TABLE XVII
LABELED CARBfl DIOXIDE PRODUCED FROM THE OXl~TlON OF
CITIATE•1,S• C BY BOHI HOMOGENATIS OF FEMUR DiAPHYSIS AND
EPIPHYSIS fORTIFIED WITH NICOTINAMIDE ADBNINE DlNUCLIOTIDE
PHOSPHATE AND PUPAltED FllC»l THYROCALCITOIUft•TUATED AND COlfTilOL
ANIMALS

QJAfHXSI§
Experilaental

¥0DCIJ.I&!D

Sei!'\D Calcium

i!ldl

Activity

haralma 1t1.11l

IUISr•SI
Citrate•1,5-14c
Citrate-1,s-1 4c

TCT•Tn&tael'lt

8.7

Sl

TCT•Tn&taeDt

8.9

49

C1trate-t,s- 14c

TCT•Treatment

9.1

so

C1trate-1,s- 14c

Coatrol

9.2

48

C1trate-1,s-14c

CODtrol

9.4

52

Cltrate-1,s-14c

Coatrol

9.3

ss

lfJPHY§l§
llaltiSEISI
Citrate-l,s-14c
14
Citrate-1,5- C
Citrate-t,s- 14c
C1trate-1,s-1 4c
Citrate-1,s-1 4c
14
Citrate-1,5· C

EX)Htriael'ltal
¥asl&sl.a

s.,. Caleba
'all

TCT·Treataent

8.7

140

TCT·Treatment

8.9

150

TCT-Treatment

9.1

130

Activity

'sualu t!atl

Coatrol

148

Control

134

Control

9.3

139
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TABLE XVlll

LABELED CARBi>l DIOXIDE PRODUCID FR<M THE OXIDATION OF
ClTRATE-1,5-

C BY BONE HCMOGENATES OF FEMUR DIAPHYSIS AND

EPIPliYSIS FORTIFIED WITH NlCOTl~~IDE ADENINE DINUCLEOTIDE
PHOSPHATE AND PREPARED FROM THYROCALCITONIN•TREATED AND CONTROL
ANIMALS
DIAPHXSU
Experl.aental
Subl~£&$1

ggndj.~i2!l

Serum Calcium

hldl

Activity

'smlma

b9!1! l

Citrate-l.s-14c
cttrate-1,s- 14c

TCT•Tre&tment

8.4

42

TCT-Treataent

8.3

38

cttrate-l,s- 14c

TCT-Treatment

9.1

44

Citrate•l,S- 14C
Citrate-l,s- 14c

Control

8.8

4S

Control

8.7

44

Citrate-l,s- 14c

Control

9.2

47

Experimental

Sl!lz!S£•t!

gonsa&s&a

Serum Calcium
~mdl

Activity
~ SElH l!!Dil

Citrate-l,s- 14c
Citrate-l,s-1 4c

TCT•Treatment

8.4

90

TCT·Treatment

8.3

88

Citrate-l,S· 14C

TC'l'•Treatment

9.1

9S

Citrate-l,s- 14c
Citrate•l,S- 14C

Control

8.8

91

Control

8.7

92

Citrate•l,s-14c

Control

9.2

93

gPtPHJ:S\S
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two control animals reeeived no injt:ction whatever.

Twelve

hours after the last doae of Injection Parathyroid, two of the
four animals each received IS mg of thyrocalcitonin TCA powder

dissolved in 0.01

! acetic acid and administered in the form of

two injections of one-half ml each over a two hou.r period.

Serum calcium levels prior to sacrifice in the PTE-treated, PTETCT-treatment aDd control animals are indicated in the Tables
XIX• XX and XXI.
Bona hamoganatea were prepared and one-half microcurie of

IUbatrata was introduced i.Dto each flask aa well aa 4. 0 al of
bone homogenate and sixteen aicromolea of NADP.

The incubation

was carried out at 37° C for three houra in a constant t•pera•
ture shaker water bath.
The reaulta of the three experiments (Tables XIX, XX and
XXI) indicated that the bona diaphysis aDd epiphysis prepared
from PTK•treated anlatala proclucea a areatar amOUDt of

1 4c~

from substrata than does bone diaphysis an4 epiphysis prepared
fran PTE•TCT-treated animals.

Produc:tlot'l of 14 co

2 from sub-

st:ratEJ in the bone preparation fram PTE·TCT-treated animals ia
greater than that produced fran the control animals.

rgns.t&:tcl uwosaat•• g(
Bone P£tpareg frqp thg Diaphyfi' fRd Eptehytia o( fii•Treatld.

IXJ?trimet 2Q;

Tht Ipcubttlga 9( MPP

PTE·TCT•IreatE apd Cogtnl Aglm!lt !d,tl} §ygc;1Dftt=2 1 3-14q,
Six thyroparathyroidectomized anill&la were used in the
axperiaea.t.

Twenty four houn after aura•ry• four of the six

TABLE XIX
72.
EFFECT OF PARATHYROID EXTRACT ALOME AND PARATHYROID EXTRACT
TOGETHER. WITH THYROCALCITONIN IN Vl VO ON THE lABEL~ CARBON
DIOXIDE PRODUCED FR.CM THE OXIDATION OF CITRATE-1 1 .5- 4c BY
HOMOGINATES OF FIHUR DtAPHYSIS AND EPIPHYSIS PORTlPIED WITH
NICOTINAMIDE ADENINE DUWCLEOTIDE PHOSPHATE

!UAI:Itll§
llal!IS:,.£1

Ex~imellt:al

C2!11!S19.9

Set:'\Ul\ Calcium
.~m!1.l

Activity

'SJlm.lms. ..bone l

Cltrate-t,s-14c
Ct.trate-t,s- 14c

PTE

13.5

99

PTE

13.2

98

Citrate-1,.5· 14C

PT!

13.6

103

Citrat:.-1 1 .5- 14C

PTE•TC'r

10.7

sa

Cltrat.-1,.5·14c

PTE•TCT

11.2

.56

Cit~rate-l,S· 14c

PTE•TCT

11.2

ss

Cltrat.-1,5- 14c

Coatnl

9.8

20

C1trate-1,.5·14c

Control

9.8

19

Cltrat.-1,5·14c

Control

10.2

19

ll!lEIJISI§
IY!liiE!!il
Citr:ate-1,.5·14c

Experiaental
Clll!llSl:lll

Seruat Celoba

Clt~rate-t,s-1 4c
Citrate-t,s- 14c

'!!dl

Activity
'SRmbDI b!Ul

PTE

13.5

190

PTE

13.2

182

PTE

13.2

174

Citrate-! ,s•.l 4c
Cltrate•l,S- 14c

PTE•TCT

10.7

119

PT!·TCT

11.2

131

ct.trat.-1,s- 14c

PTE,-TCT

11.2

134

Cltrate-1 1 .5- 14C
C1trate-t,s- 14c

Control

9.8

82

Coatrol

9.8

16

Ct.trate-l,s- 14c

Ccmtr:ol

10.2

70

TABLE XX
73.
EFFECT Of PABATHYI.OID EXTI.ACT ALONE AND PARATHYitOlD EXTMCT
TOGETHER WITH THYROCALCITORUf
.!1.!.2 ON THE LABEL~ CARBON
DIOXIDE PRODUCED FROM THE OXl TlON OF CITRATE•1,5· 4c BY
HOHOGIMATES OF FEMUR DIAPHYSIS AND EPIPHYSIS FORTIFIED WITH
NICOTlftAMIDI AD!NlNI DlftUCLEOTlDE PHOSP~TI

ott

I!IAPUI§il

!xperiaental
C!J!d&li!D

SJ!J!!IE!II

Sel.'\llll C& leb.-

'ull

Aetlvity

'SR!!llll ~-ll

14
Citrate-1 1 5- C
Cltt:ate-1,5-1 4c

PTE

14.0

106

PTE

13.7

99

Citrate-1,s-1 4c

PTI

13.1

116

C1trate-1,s- 14c
Citrate-1,s-1 4c

PTI•TCT

11.6

91

PTI•TCT

11.4

85

Citrate-1,s-1 4c

PTE•TCT

11.5

83

Cltrate-1,s- 14c
C1crate•1 1 .5·1 4c

Coatrol

9.8

52

Coatrol

9.6

.52

Control

9.7

66

Cltrate-1,5·

14

C

~==
Cltrate-1,s- 14c

Expertaeatal
C'DSfll&ll

Serum C& leba

'•dl

Activity

'••lu

PTE

14.0

PTE

13.7

450

PTE

13.8

380

PTI•TCT

11.6

25.5

PTE•TCT

11.4

262

PTE•TCT

11 • .5

271

Cltrate-t,s- 14c
Cit:rate-1 .5· 14C

Control

9.8

230

Control

9.6

21.5

Cltrate-1,s- 14c

Control

9.7

235

Cltrate-1,.5- 14c
Cltrate-1,5- 14c
Citrate•l,S· 14C
Citrate-t,s-14c
14
Citrate-1,.5· C

1

404

J!&ll
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TABLE XXI
EFFECT OF PARATHYROID EXTRACT ALONE AND PARATHYROID EXTRACT
TOGETHER WITH THYROCALCITONIN lJ! RON THE LABEL~4CARBON
DIOXIDE PRODUCED FROM THE OXI~TIOR
CITRATE-1,5- C BY
HOKOGENATES OP FEMUR DLAPHYSlS AND EPIPHYSIS FORTIFIED WITH
NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE
DIAP!!IS&S

1\!lit•!U!I

Experimental
~2!!!\l.Sigg

Serum ca lc:ium
~!ldl

Activity

's•lu

Citrate•1,5- 14c
14
Citrate-1,5- C
C1trate-1,S- 14c

PTE

13.1

274

PTE

12.9

2S4

PTE

13.2

265

14
Cltrata-1,5- C
Citrate-1,s- 14c

FTE•TCT

11.1

200

PTE•TCT

10.9

192

C1trate-1,s- 14c

PTE•TCT

10.8

197

Citrate-1,5- 14C
14
Citrate-1,5- C
Citrate-l,s-14c

Control

9.2

197

Control

9.4

189

Control

9.1

212

Experimental

Serum Calcium

~P&P!!XS&S

SJ!ll!!E8 b

Cltrate-t,s-14c
Cltrate-l,s- 14c
14
Cltrate-1,5- C

~-di!12!!

.~mdl

Activity

,&!111!11 bQDil

PTE

13.1

sso

PTE

12.9

S10

PTI

13.2

S6S

14
C
Citrate-1,s- 14c

PTE-TCT

11.1

458

PTE-TCT

10.9

421

Citrate•1,S· 14C

PTE·TCT

10.8

436

Citrate•l,S- 14c

Control

9.2

420

Citrate-t,s-14c
Citrate•t,s- 14c

COI'ltrol

9.4

470

Control

9.1

439

Citrate-1,5-

llo!!! l

7S.
antmala received 100

u.s.P.

unite each of Injection Parathyroid

over a pel"iod of two days ln

two

ctoaea of SO unite each.

two control animals received

no injections.

the laat doae of Injection Parathyroid,

The

Twelve houra after

two

of the four antaala

•a of thyrocalcitonin TCA powder wbich waa
diaaolvad in 0.01 ! acetic acid and adainiatered in the for,a
each received 15

of

two inject lone of one•half al each over a tvo hour period.

Serum caloiua levels prior to sacrifice in the PTE-treated,
PTE-TCT-treatmeat and control anlmals averaaecl are illdieatect in

Table XXII.
loae h•oaenatea were prepared aDd one-half microcurie of
substrate vaa iatroducect into each f laalt aa vall ae 4. 0 al of
bone homosenate and aixteen aicroaolea of

~DP.

The incubation

waa carried out at 37° C for three houn in a conatant t•per•
ature shaker water bath.
As ahowa in Table XXII the results of the experiment

indicate that the bone prepared froa PTE•treated aaiaala produces
14
a sreatel:' amaunt of
co2 fi:'OIIl subatrate, than doee bone
prepared frG!l PTE-TCT•tr:eated aniuls. Production of 14c<>a frcm
eubatrate in bone prepared frca PTE-TCT•treated antmala ia
greater than tbat produced from cumtrols.

Thia pattern ia

observed in the preparations of both the diapbyaia and epipbyaia.

TABLE XXII
•
EFFECT OF PARATHYROID EXTRACT AI..oru:: AND PARATHYROID EXTRACT
TOGETHER WITH THYROCALCITONIN lfi Ill'.Q ON THE LABELED ~RBON
DIOXIDE PRODUCED FROM THE OXIDATION OF SUCClNATE-2,3- C BY
HOMOGENATES OF FEMUR DIAPHYSIS AND EPIPHYSIS FORTIFIED WITH
NICOTINAMIDE ADENINE DINUCLEOTIDE ~tOSPHATE
DJ!PJ.fiSlS..

Experimental

Serum Calcium

Activity

'mdl

'S'Ii!!Jbn& bonel

PTE

12.6

124

PTE

13.1

11S

PTE

13.1

126

14
C
Succ1nate-2,3- 14c

PTE•TCT

10.4

85

PTE-TCT

10.6

9S

Suceinate•2,3·14c

PTE•TCT

IO.S

80

Succinate-2,3·14c
Suceinate-2,3- 14c

Control

9.6

70

Control

9.9

75

Succinate•2,3·14c

Control

9.9

85

Experimental
Cgndi:ti!D

Serum C&lelum

Syb!tra!;e

Succinate-2,3- 14c
Suceinate-2,3·14C
Suecinate-2,3-1 4 c
Suecinate-2,3·

iflP!!X§l~
~l!J21Si£Atl

Cons;tlt~sm

hu&~l

Activity

';mn4ma

bon!~

14
C
Suoeinate-2,3-1 4 c

PTE

12.6

1,200

PTE

13.1

1,190

Succ1nate-2,3- 14c

PTE

13.1

1,210

Succinate-2,3- 14C

PTE•TCT

10.4

910

Succinate-2,3-14c
Succinate-2,3-1 4c

PTE-TCT

10.6

920

PTE•TCT

10.5

1,010

Control

9.6

92S

Control

9.9

9SO

Control

9.9

960

Suceinate-2,3·

14
C
14
Succinate-2,3- C
14
Succinate-2.3· C
Succinate-2.3·
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Ihe Iggubation of NAOP FO£t1f1!9 ftomoatnatea of

E!2•riment 21:

5ont PreE!rftd from the Dia2hysis and EQiRhltia of

PTI·Trtet~ 1

PTE·TCT·Treatad and C?ntrol AnJ.m!ls witb 2-Qxoglutarate-s-

14g.

Six thyroparathyroidectamized antmala were used in the

Twenty four hours after auraery, four of the six

experiment.

ant.als received 100

u.s.P.

units each of Injection Parathyroid

over a period of two days in

two

doses of SO units each.

two eontrol animals received no injeetiona.

The

Twelve hours after

the last doae of Injeetion Parathyroid• two of the four animals
eaeh reaeiv.t 15

as

of thyrocalcitonin TCA powder which waa

administered in the form of two injections of one-half ml each

over a

two

hour period.

Serum calcium levels prior to sacrifice

in the PTE-treated, PTE·TCT-treahlent ad contJ:ol animals
averaged 13.1

ma~.

11.6 IJlS'I and 10.1 ms'Xt reapecti vely.

Bone ha.ogenates were prepared and one-half microcurie of
substrate was introduced into each flask aa well as 4. 0 ml of
bone homogenate aad sixteen mieromoles of NAOP,

The incubation

was carried out at 37° C for three hours in a c:onataat tempera-

ture shaker water bath.
The results of the

exper~ent

ahown in Table XXIII indicate

that the bone prepared fr• the PTE-treated ani.Jaala producea a

greater amount of

14

co2

from. wbatrate, tban does bone prepared

from PTE·TCT-treated animals.

Proctuction of 1 4 c~ frCJm

aubstrate in bone prepared frora PTE•TCT-treated animals ia

greater than that produced fr• coratrola.

This pattel:'n is
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TABLE XXIII
EFFECT OF PARATHYROID EXTRACT ALONE AND PARATHYROID EXTRACT
TOGETHER WITH THYROCALCITONIN IN VIVO ON THE LABELED CARf~N
DIOXIDE PRODUCED FRC»t TH~ OXIDATIO'N'OF 2-0XOGLU'fARt\TE-5- C BY
HOMOGENATES OF FEMUR DIAPHYSIS AND EPIPHYSIS FORTIFIED WITH
NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHaTE
DIAPHYSIS
Substrate

Experimental
Condi.tion

2-0xoglutarate-5-14c
14
2-0xoglutarate-5- C
14
2-0xoglutarate-5- C

Serum Calcium Activity
~ c;emlm!5 bonel
~mg~}

PTE

12.9

104

PTE

13.4

90

PTE

13.0

96

2-0xoglutarate-5- 14C
2-0xoslutarate-5- 14C

PTE·TCT

11.5

61

PTE•TCT

11.8

57

2-0xoglutarate-5·14c

PTE·TCT

11.5

55

2-0xoglutarate-s-1 4 c
2-0xoglutarate-5- 14C

Control

10.0

33

Control

9.8

35

2-0xoglutarate-5- 14c

Control

10.5

32

.EPIPHYSIS

Experimental

Sy:2strat~

Qongit~2D

Serum Calcium Activity
~m&Ztl

~c11J!:.Lms bon!l

2-0xoglutarate-s-14c
2-0xoglutarate-5- 14c

PTE

12.9

420

PTE

13.4

415

2-0xoglutarate-s-14c

PTE

13.0

430

PTE·TCT

11.5

380

PTE·TCT

11.8

371

C

PTE-TCT

11.5

368

2-0xoglutarate-5- 14c
14
2-0xoglutarate-5- c
2-0xoglutarate-5- 14c

Control

10.0

342

Control

9.8

386

Control

10.5

372

2-0xoglutarate-5- 14c
2-0xoglutarate-5- 14c
2-0xoglutarate-5-

14
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obaervad in the preparations of both the diapn,ata and epiphyaia.

II"'MI!S 22: tbt lJKN!tf!lg of MDP Forti fiE Hcaoapatea of
l19t P£1R!tt4 ftll She P&•Rbf!i! !Dd Epipbfsls of PTI•Tf!!5td•
14
rii·TCI•tnated yd Gsmtnl Ap\Ml! with Pnuyate-2- g.
Six thyroparathyro:ldec:t•ized animals wen used in the
experiment.

'l'vety four hours after surgery • four of the s1.x

an~als reoei~

100 u.s.P, units each of Injection Parathyroid

over a period of two days in doses of 50 unite each.
control animals received no iajec:tiODa..

The

Twelve hours after the

last dose of Injection Parathyroid, two of the four antaala each
received 15 •& of thyrocalcitonin TCA powder which waa adlliniatered tn the form of tvo injections of one-half al over a two

hour period..

Serum caleium levels prior to aacrifiee in the

PT!•trflated, PTI•TCT•trea1:1Deat and control animals averaged

12.8 mg1., 10 .. 9 ma% and 9,7 mat. Z"Upectively.
Bone homoaeft&tea were prepared and one-half microcurie of
substrate waa introduced into eacm flask aa well aa 4 .. 0 al of
bone hcaoaenate and sixteen

aicr<~Dolea

of MDP.

The incubation

was carried out at 37° C for three hours ill a constant t•pera•
ture srut.ker water bath,
The reaulta of the exper1aent aivan in Table XXIV indieate

that the bone prepared frOIIl the PTE-treated anima. ls produees a

&r~at:er

a'liount of

14

cv2 from aubatrat:e, than doea

fram PTI•TCT-treated anlmala.
in bone prepared

fro.·;~

14co from substrate
2
animals is greater than

Production of

~~E·TCT-treated

bone pr.euared

so.
that produced frOID controls.

Tbia pattern ia observed in

the preparations of both the diaphysis and epiphysis.

TABLE XXIV
.st.
EFFECT OF PARATHYROID EXTRACT ALONE AND PARATHYROID EXTRACT
TOGETHER WITH THYROCALCITONIN 1! .!1!.2 ON THE LABELfi CARBON
DIOXIDE PRODUCED FROM THE OXIDATION OF PYRUVATE-2· C BY
LABELED HCHOG~TES OF FEMUR DIAPHYSIS AND EPIPHYSIS
Experlaental

g~£111111
Syl!I~E!Jil

gcmdi~l-

Pyruvate-2- 14c

Ser:ta Calcium

'•dl

Activity
'CDil/11 b&!l
101

PTE

12.6

PTE

13.0

102

PTE

12.8

98

PTI•TCT

10.7

74

PTE•TCT

11.3

80

PT.E•TCT

10.7

79

Pyruvate-2-14c
PyJ:uvate-2- 14c

C01ttrol

9.6

23

Coat~:ol

9.8

21

P)'Nvate-2- 14c

Control

9.7

25

Experlaent:al

Serua Cale:1UM

Pyruvate-2- 14c
Pyz:uvate-2- 14c
Pyruvate-2-14c
Pyruvate-2-1 4c
Pyru:vate-2- 14C

IllPitSII

b!IISEIS!
Pyruvate-2-1 4c
Pyruvate-2- 14c

g0Dd&Sl98

'•dl

Aetlvlty

'smalaa !!mtl

PTE

12.6

181

PTE

13.0

190

PTE

12.8

187

Pyruvate-2- 14c
Pyt:uvate-2- 14c

PTE•TCT

10.7

159

PTE•TCT

11.3

167

Pyruvate-2- 14c

PTI•TCT

10.7

156

Pyruvata-2- 14c
Pyruvate-2- 14c

Control

9.6

124

Control

9.8

114

Pyruvate-2-1 4c

Control

9.7

119

Pyt:uvate-2-

14
C

CHAPTER IV

DISCUSS IOR
The work contained in thla dleaert:ation waa initiated in an
attempt to explain the apparent dual metabolic reaponae to
parathyroid extract injectlon which waa reported by Cohn (27).
He indicated that epiphyaeal•metaphyaeal fauur slices prepared
fro. PTI•treated rabbits aetabollzed alyeolyaia inter:aediatea
to a areater extent than did c•parable eontrol preparations,
while aS..ilar preparations showed a marked depression in the
metaboll• of l.reba cycle

intU~Dediatea.

There is no poatulated

mataboU.c pathway which could account for thla phencaenon.
Yatea et al. (117) alao prelented evidence that PTE doea
have a dual metabolic role 1.n bone tilsue.
of endogenous PTH via peritoneal lava&••

He ..,.ried the levela
After aacriflce of the

lavaaed animal, the faaura W8re r.oved arad separated into
metaphyses (trabecular boae) and diaphyaia (o•pact bone) in
preparation for ineubation.

By meaeurina citrate and lactate

COilcentntiODa present ln tbe media, it vaa d-onatrated that
citrate production vaa areater in the

diap~aia

and lactate

production was areater in the metaphysis.
The work indicates that the dual metabolic effect produced
by the adainiatration of parathyroid extract mi&ht be explained
by the cellular differtmCtea of e011pact and trabecular bone.

effects of PTH

Gil

citn.te productiOD an seen mainly in the

diaphysis of the femur.

The moat numerous cell type of the

The
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diaphysis is the osteocyte althouah osteoblast• and osteoolasts
are also present.

The epiphyseal cell types include a mixture

of mesenchyme cella, osteoblast•• oeteoelaats and ostaoeytes.

ln seneral, the structure of the epiphysis ls less hi&hly
organized than that of the diaphysis.
Experiments presented by DeLona ( 3.5) eonfll!'ltutd the dual

response ln boDe tleeue fraptmta.
have been recalculated

Oil

R.epreseatative experiments

the 'basta of opm of evolved

C~/mg

bone to facilitate c•pariaoa vU:h the expertaents described
in thil dislartatlon.

TABLE XXV

R!SfP-S! OF BONE TISSUE FRAGHEJttS TO PTE•TREATKDT AS MANIFESTED
BY

co2

EVOLUTION Flt<»t lABELED SUISTJATE

Diapb.yats
IMZ.I b29!

Activity
Epiphysis
e;mlma boge

PTI

26

21

CODtrol

50

11

PTE

30

77

Control

43

S4

PTE

373

883

Coatrol

230

.583

Activity

§ubatrtt•
Citrate-1,5-1 4c

tnatmas
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In general, the response shown in the metaboltam of Krebs
cycle acids (citrate aDd succinate) incubated with bone prepared from PTE•tr:eated animals was that of a depression in
14 co evolution in the diaphysis and a at~lation in the
2
epiphysis. However, this pattern is not observed during the

incubation of pyruvate-2-

14
C with comparable bone prepar:aticns.

Since the structures of eompact and trabecular bone are
quite different • haaoaenizaticm was aaplcyed to obtain more

comparable and uniform preparations.

The homogenized bone is

not fully viable unless exogenous NADP is added.
was also reported by Mecca et al. (78).

This fincU.ng

Results of the incn.sba•

tiona of the labeled substrate with NADP fortified hoaogenates
may be summarized as follows:
TARLE XXVI
RESf~SE

or BONE H<MOOIMTI TISSUE TO PTE-TREATMENT AS MANIFESTED

co2 EVOl.UTlON FRGi lABELED SUBSTRATE
Activity
Diaphysis
TreaS!!Mt
iubetntt
SJi!!lu ~tons
BY

Citrate-1,5-

14

C

124

375

S6

285

1200

2495

Control

890

1985

PTE

268

664

Control

208

378

PTE

Control
PTE

Pyruvate-2-1 4 c

Activity
Epiphysis
s•lma bRU

8.5.
Tba metabolic pattern re.ultina fro. a coapariaon of the
oxidation of Krebs cycle aeida by MDP fortified bone bGnlogen•
atea prepared fr• PTE-treated and cntrol an1mala indicates an
increase la 14co evolution fraa labeled substrate in both the
2
diaphyeis and epiphysis preparation obtained frem the PTE•
treated aatmala.

Thla same pattern ia obserwd durin& the
incubation of pyruvate·2- 14c with a ..parable bone preparation.

Tbe data indicate that the metabolic reapoBse of PTE ia
probably a reflection of the differences in physical structure
of trabecrular al'ld eoapaot .__e rather than a function of
cellular distribution or unique metabolic pathways.

The d1&•

physis contains bi&hly oraanized Haversian ayateD wbich
contalaa viable cella deep within the aineral matrix.
iatact • it would take loaaer for

ia~~

Left

to diffuse into the cell

in the Haveraian ayat•• than auob a dlffualoa in the structurally 1esa oraaaized eplpbyala.

Dlapbyaia coataina 1eaa viable

cella on the aurlaee of the alaua1 than epipbyala.

The

epipl\yaia la the chief arovtna ancl r•odelina center of bone and
coataiaa a blah cODeentratiOD of cellular uter1a1 ia the
epipbyaeal plate area.

Therefore dlffuaioa of isotope into the

cella contained in eoapaet and trabecular boae probably proceeds
at different rates if the tia.ue structure ia left relatively
intact Which it would be in bone fa-apent preparations.

Thia

variable is eliminated by hoaaoaeaS.zina the bone tieaue to a
8Jaall unlfon particle aize.
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Bone tiaaue can incorporate citric acid aa well as other
Krebs cycle oraanlo aoida into the mineral matrix.

Thia occurs

to a greater extent in reaorbina areas in the stable calcium
ccmpartment.

Krebs cycle acids are incorporated into the open

apaoea in the partially resorbed crystal lattice.

The diaphysis

is mineralized to a greater exteDt tbaft the epiphysis in the
relatively YOUR& animals used in these expert-ants.

Therefore

the diaphysis of the PTI•treated aniaal vlll tend to bind more
tracer acid tban will the

diap~sla

of control animals, since

PTE•treated animals have more resorbina sites.

Tbia would

effectively reduoe the amount of available tracer and thus &iva

an erroneously low rate of metabolism in the diaphysis of PTE·
treated animals.
broken

Haaoaenization will equalize the DUaber of

crystal lattice sites in both PTE and control prepara-

tions, thu.a equalizia.a &Dy substrate biD41D& differences.
Four aicraaoles/ml of haaoa•ate is the optimal concentration of MADP necessary to obtain a fully viable bone homoaeaate.
At concentratiOl'la leas tban tbat •CR.ul1: 1 the ayataa ta apparently
not seDsltlve to hormone treatment, or it will exhibit a
different metabolic pattern.
Evidence baa been

presen~ed

which indicates that the

metabolic chana•• asaoclatecl with the .&du&iniatration of PTE are
not a direct fuaction of PTH action.

Purified PTH has no effect

on clycolylia in Erhlich Ascites tumor cells.

However, non-

hypercalca.ic fractions from the gel filtration purification
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of PTE does have a metabolic response in this assay similar to
that pro4uced by PTE (.52}.
Aurbach et al. (8) has shown that several metabolic
responses previously attributed to PTE aetion in kidney homo•
genates• can be duplicated with non-hypercalcemic peptides.

ln particular, the reported PTH•induced stimulation in ion
transport and mitochondrial respiration believed to be involved
in the mechanism of action of calcium homeostasis, can be
duplicated in a comparable

in yit£2

syat•~

usin& non-hyper-

calcemic fraetiona obtained durin& purification of parathyroid
hormone as well as basic proteins such as polylysine and ?rolami.ne.

The alterations in metabolism produced by the injeetion
of PTE can be meaaured up to 48 hours after injection.

However

the half-life of PTH bas been estimated to be 20 minutes. Even
so, the serum calcium levels remain elevated 24 - 48 hours after
a pharmacoloaical dose of PTE.
To study the possible relation between the elevated levels
of aerum calcium and metabolltm, bone ha.uo&enatea prepared ln

media containina various concentraticma of calcium ion were
incubated with pyruvate-2- 14c. This substrate was chosen

because of ita relatively central position in the metabolic
pathways of bone.
in Table XXVll.

The results of the experiment are aummari.zed
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TABLE XXVII
IISPONSE OF BONE JiSSUE PREPAMTIOM TO

AS MANIFESTED IY

Madia ca++

till

l»l!ISDII
Py&uvate-2- 14c
Pywwte-2- 14c
Pyruvate-2•

6

JJ! YITIQ

CALCIUM LEVELS

EVOLUTION PlOH LABELED SUBSTRATE

~

Aeti'ri.ty
Diapbyala

a•7ma :UU

Activity
Epipbyaia

SWI!I 12!!!1

14 q'J,

162

353

10 •&'~.

134

294

6 .,,

88

205

14

C

Aa the aalcba ecmeeatrati.on of the aedlwa was i.ncreaaect fr
14
to 14 ••"• the evolution of
co2 waa laereaaed fr• 88

q"

cpa/aa boa• to 162 epa/raa bODe lll the dlaphyala and 205 cpa/a&
to 353 opa/aa bone ln the eplpbyala.

ln order to aaaertat.D whether or not the alteratiODa in
aetaboll. . of pyruvate-2-14c produced ~ varyiaa 1a yitro calcium

ion le.ela are eeaparable to the alteratlcma 1D aetaboll . .
produced by varyl.aa .&a

pD auum ealab.a 1 bone tlaaue obtai.Ded

fr• tbyroparat:byroldeotGal&ed t:'&ta aaiatalned em a aomal and
a aalciua•deflcleat diet waa prepared for iaeubation (Table

XXVlll).
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TABLE XXVIII
ESPONSE OF BONE I!SSUE PREPARATION TO .1l! !.UQ CALCIUM LEVELS
S MANIFESTED BY
co2 EVOLUTION FROM LABELED SUBSTRATE

lUt.!1
Noxmal
Caleb•·
deficient

sraZma l!n•

Activity
Epiphysis
s•lma bgpe

10.6 ••,.

123

370

8.5 ••,.

93

225

Averaae ++
Strp C!

Activity
Diaphysis

The results indicate that the tissue prepared from tbe
taala which have the lower aerua caloiua values also have a
ower rate of bema metabolism.

It does appear then, that the

evela of calciUM can influence the rate of metabolism both
.-...... and

1a

iD :!lJ!2

In order to elaborate on this pr.,ise, the rate of
etabollam in antmala made hypercalcemic and hypocalcemic by
treatment was W'ldertaktm.

The initial aoal in this

phase of the experimental work was to detenalne rates of meta•
bollm in normal animals and animals lll&de hypocalc-ic by
injection of thyrocalcitonin (TCT).
experiments appear in Table XXIX.

Tbe re.ults of these
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TABLE XXIX
RKSPOftSE OF JONE TISSUE PREPARATION TO TCT·TREATMENT AS MANIFESTED BY 1 C02 EVOLUTION PROM LABELED SUBSTRATE

Activity
Activity
Di&P.hyaia
Epiph7aia
s.Zu bne seZu bog•

Subatrats
14
C
C1trate-1,5- 14c

Citrate-l,S-

Control

9.3

52

140

TCT

8.9

so

140

The data indicates that the 1light depression of serum
calcium produced by the a4alniatration of the particular dose
level of TCT has no aipificant effect on metabolism.

Apparently

metabolism ia sensitive only to lara• changes in calcium con•
eentration.
Animals are more sensitive to any given dose level of TCT
if they are in a state of b¥perc:alcemia.

In this regard, a

greater sensitivity to TCT can be developed in animals by pre•

treatment with PT!.

The animals made hypercalcemic via PTE

administration wi 11 show a area tar decrease in serum calcium
than that decrease in serum ea lci\a produced by the same dose

level of TCT injeetecl into an ani.Jilal WS.th normal serum ealciura
level.
The aeries of experiaents in the latter portion of the
dissertation were desiped to study bcme metaboli• at three
differet'lt levels of Ja.

.!d.:!2

calciUII loa coraceratrations.

results of the experimet'lts appear in Table XXX.

The
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TABLE XXX
RESPONSE OF BONE TISSUE PREPARATION 1'0 PTE tND P'!E \HTH
SUBSEQUENT TCT·TR.EATMENT AS YJANllESTED BY 1 C~ 1!VOLUTIOif FRQt

LABELED SUBSTRATE

I:YI!ISE•S!
C1trate-1·1 S· 14C

Suecinate•2,3-14c

Activity
Activity
Average ++ Diapbyaia
Epiphysis
Ia!lm!Bt Ita 9! snplps bo!!• sial•& bema
PTE
13.3 q'&
100
182

PTB•TCT

11.1 • .,.

56

128

CODtrol

10.0 . .,.

19

76

PTE

12.9 .....

121

1,200

PTE•TCT

10.5 ·~
9.8 ••,.

86

946

76

945

13.1 .,,

96

421

57

339

Control

11.6 -~
10.1 .....

33

366

PTE

12.8 ..,.

100

186

PTE·TCT

10.9 ••,.

77

160

•aft

23

119

Control
2-0xoslutarate-s- 14c PTE

PTE·TCT
Pyruwte-2- 14c

COiltrol

9.7
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The data indicates that the level of metabolic activity
in the bone preparations of diaphysis and epiphysis seems to
reflect the level of serum calcium.

Hypercalcemia produced by

injection of PTE is associated with increased bone metabolic
activity compared to the control bone preparations with all
substrates tested.

Injection of TCT into teat animals made

hypercalcemic by the administration of PTE appreciably reduced
the hypercalcemia.

Concomitant with the reduction in serum

calcium, a reduction in metabolic activity of the bone preparations was also observed.

CHAPTER V
SUf'1HARY AND CONCLUSIONS

1 t has been noted by numerous reaearobera that the
administration of Parathyroid Extract to
a dual metabolic response in bone.

~e~t

animals

~r~duees

The results of others aa

well as the data pnsaDted in the beaini.D.a of the Experimental
Chapter of this dissertation indicate tbat the oxidation of
alycolytic intemediatea ia increased durin& the incubation of
surviv1na fanur epi.pbyaia frapents while the oxidation of Kreba
cycle lntez:medlates ia dillinlshed durin& the incubatloa of
aurvivt.na f•ur diapbysia frapents.

{Table XXV).

However,

wben the bone tisauee are hoaoaenlzed aad adequate a.ourats of

MDP are &deled to reconstitute the syat• oae observes a
at~ulatioa

in the oxidation of both Krebs cycle and glycolytic

intermediate in f..ur diaphysie and epipbyals prepared from

PTE•treated antaala (Table XXVI).

H•oseralzatioa of these

tissues ainlad.zes the inherent physical and aubatrate bindin&
differences wbicb aay account for the pattern observed in
studies usina intact or frapeatt.aed e•paet aad trabecular bone.
A consisteat patten of oxidat'ive reeponee to PTE is in iteelf
aore lopeal thAD t'he pnviouely reported 'dual' aetabollc
reaponse, since there are no recoanized aetabolic pathways which
could account for the • dual 1 response.
Coba &Del Forsoher: (26) reported that 851. of the total
alucose present durlna ineubation with bone was oxidized via
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glycolytic - Krebs-cycle pathways While
the pentoae shunt.

15~

was metabolized via

Therefore the majority of the labeled

C~

produced frCIIl substrates durin& borte metaboli• ia c:lue to Kreba
cycle acti:ri.ty.
The metabolic activity of bone hoaoaenate la increased ••
the level of 1a Jltrt calcium loa is increased (Table XXVII).
Alao, bone h•oaenate prepared fraa thyroparathyroideetoml.zed
antaala maintained on a ealeiua•deflcient diet show. a lower
metabolic activity thaD bone haaoaenatea prepared fro. the
thyroparathyroidect•ized rata aaintained on a normal diet
(Table XXVIII).

These ant.ala also maintained a lover serum

calciua tb.ala did animals on a llOJ:aal dlet.

1D

vltro and

1 t appears that both

!!1 .J1:l.t levels of calciua ion can influence bone

metabolism.
TCT aCS.lniatered to thyroparathyroidectOIIllZecl rata produces
a very aliaht deereaae ln aerua calcium and baa no aiplf icant
influence on bone metaboli . . (Table XXlX).

However, if the

same dose level of TCT ia lajeetecl iato an animal made
hypercaleeaic by prior adaialatratlon of PTE, the reaultaat
marked decrease in aeZ'Uil calclua ia aeeompanled by a ai&nlficant
decrease la bone aetaboll• (Table XXX).

The decrease in

metaboll.. muat be a direct result of the decrease in aerum
calclua since the adalaiatratitm of the ••• dose level to a
nor,mal antmal produced a all&ht fall in serum calcium but no
alpificant chana• in bone metaboliam.

95.
The data presented in the dissertation is the first direct
evidence of the influence of calcium ion concentration on the
ox.idatiOD of substrates in bone.

It has been d•onstrated that

PTH does not influence the oxidat:ioa of 11\lbat:ratea ( S2).
Current evidence indicates tbat this hormone initiates bone
resorption by promoting the release and synthesis of bone des•
troyiD& enzymes (38).

In evaluatina the role of bone metabolism

in the overall role of bone reaorptiOD and accretion, one mi&ht
speculate that aa bone resorption proceeds, intracellular levels
of calcium can increase.

Increased intracellular levels of

calcium durin& bone resorption can produce, according to the
experimental evidence presented herein, an increase in bone
metabolisa which in turn can produce a localized acidosis at
the area of resorption.

An acidic aedlum at the site of

resorption will favor reaorption, since almost all of the bone
destroying enzymes are acid hydrolaaes.

TCT baa been shown to

promote the accretion of calcium into bone.

Calcium accretion

will probably involve a decrease 1ft the intracellular levels
of calcium.

Such a decrease according to the data presented in

the dissertation, will reduce the cellular acid products (ie.
cellular acidity) and tbus diminish the activity of the acid
hydro lases.
In conclusion, one can state tbat bone metabolism is no
lonser believed to be the prtmary eontrollin& mechanism of bone
resorption and accretion •• proposed by Neuman and Meu.an (82).

96.
However. it is poaaible

~hat

the rate of bane metabolism as

influenead by the intracellular calcium l•veta ean aet as a
eeooradary control meehaftl• which pro'ri.dee an optlmal aeidie

cellular

l.tttdl\D for the ...,.,.•• of bone

reaOE"ptlon.

A stbu•

lation ln metaboll88 produced by lnereaaed caleiua levels
durlft8 reaorpt:lon. would favor resorption by eausins increased
aeotaulatlon of tbe aeid products at metabolilll thus producina

• loealized acidosis.

The activity of the aeld hydrolase•

involved ia resorptlOft would b4t l.l'lO'Nilsed ln the actdlo medium.
This poaeulate mlaht aeoount for the fact that aeJ:Um calcium
levels r . . .tn elevated up to 24 • 30 hours after the injection
of PTH e'Mft thouah the half life of the h.ctmone has been shown

to be 20 •lautes.

Corrvereelyt lajeotlcm of tb.yroealelt•lft will an:est bone
resorption and the iratraeellular lewla of ealelua ion will
probably deereaae.

The decreased oxldatlw rate due to rela·

tlvely low 1atraeellular ealelum lewla would retard the

aecnaulatlon of the acid products of metabolism aod thus rata1'd
the aott .S. cy of bone destroyiftg -.z,.es.
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